From: Subject: Testicular Cancer: Questions and Answers - National Cancer Institute Date: Wed, 27 Jun 2007 12:18:52 -0600 MIME-Version: 1.0 Content-Type: multipart/related; type="text/html"; boundary="----=_NextPart_000_0000_01C7B8B5.52D8A6B0" X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.3138 This is a multi-part message in MIME format. ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable Content-Location: http://www.cancer.gov/cancertopics/factsheet/Sites-Types/testicular =EF=BB=BF Testicular Cancer: Questions and Answers - National = Cancer Institute
3D"skip
3D""=20
3D"U.S. 3D"National
In English | En=20 espa=C3=B1ol
3D""=20
3DSearch=20
3D""=20
3D""=20
3D""=20
3D"NCI 3D"Research 3DNews=20 3D"About
3D""=20
3D""=20
3D""=20 3D"National 3D"National 3D""=20
3D"In
    Reviewed:=20 05/24/2005
3D""=20
3D"" Page=20 Options
3D""
3D""=20
3D""=20
3D"Print   Print=20 This Page
3D""=20
3D"E-Mail   E-Mail=20 This = Document
3D""=20
3D"PDF   View/Print=20 PDF
3D""=20
3D""=20
3D""=20
3D"" Search Fact=20 Sheets by Keyword
3D""
3D""=20
3D""=20
3D""=20
      
3D""=20
3D""=20
3D""=20
3D""=20
3D"" View Fact=20 Sheets by Topic
3D""
3D""=20
3D""=20 Cancer = Type
3D""=20
Risk=20 Factors and Possible Causes
3D""=20
Preventi= on

Detection= /Diagnosis

Cancer=20 Therapy
3D""=20
Support/Cop= ing/Resources

Tobacco/Smo= king=20 Cessation
3D""=20
Informa= tion=20 Sources
3D""=20
About=20 NCI
3D""=20
Cancer=20 Advances In Focus
3D""=20
En=20 espa=C3=B1ol
3D""=20
3D""=20
3D""=20
Questions about=20 cancer?
3D""=20
3D""=201-800-4-CANCER
3D""=20
3D""=20LiveHelp=C2=AE= =20 online chat
3D""=20
3D""=20
3D"" Quick=20 Links
3D""
3D""=20
3D""=20 Director's=20 Corner
3D""=20
Dictionary of=20 Cancer Terms
3D""=20
NCI Drug=20 Dictionary
3D""=20
Fu= nding=20 Opportunities
3D""=20
NCI=20 Publications
3D""=20
Advisory=20 Boards and Groups
3D""=20
NIH Calendar = of=20 Events
3D""=20
Espa=C3=B1ol
3D""=20
3D""=20
3D""=20
3D""=20
Testicular Cancer: = Questions=20 and Answers

Key Points

  • Nearly all testicular cancers are one of two general types: seminoma or nonseminoma. Other types are rare (see Question=20 1).=20
  • This disease occurs most often in men between = the ages=20 of 20 and 39. It accounts for only 1 percent of all = cancers=20 in men (see Question=20 1).=20
  • Risk factors include having an undescended = testicle, previous testicular cancer, and = a family history of testicular cancer (see = Question=20 2).=20
  • Symptoms include a lump, swelling, or = enlargement=20 in the testicle; pain or discomfort in a testicle or = in the=20 scrotum; and/or an ache in the lower abdomen, back, or groin (see Question=20 3).=20
  • Diagnosis generally involves blood tests, ultrasound, and biopsy (see Question=20 4).=20
  • Treatment can often cure testicular cancer (see Question=20 5), but regular follow-up exams are extremely important = (see Question=20 6).

  1. What is testicular = cancer?=20

    Testicular cancer is a disease in which cells become malignant (cancerous) in one or both testicles. =

    The testicles (also called testes or gonads) are a pair of male sex glands. They produce and store sperm and are the main source of testosterone (male hormones) in men. These hormones control the = development=20 of the reproductive organs and other male physical characteristics. = The=20 testicles are located under the penis in a sac-like pouch called the scrotum. =

    Based on the characteristics of the cells in the tumor, testicular cancers are classified as = seminomas or=20 nonseminomas. Other types of cancer that arise in the = testicles=20 are rare and are not described here. Seminomas may be one = of three=20 types: classic, anaplastic, or spermatocytic. Types of=20 nonseminomas include choriocarcinoma, embryonal carcinoma, teratoma, and yolk sac tumors. Testicular tumors = may=20 contain both seminoma and nonseminoma cells.

    Testicular cancer accounts for only 1 percent of all = cancers in=20 men in the United States. About 8,000 men are diagnosed = with=20 testicular cancer, and about 390 men die of this disease = each year=20 (1). Testicular cancer occurs most often in men between = the ages=20 of 20 and 39, and is the most common form of cancer in men = between=20 the ages of 15 and 34. It is most common in white men, = especially=20 those of Scandinavian descent. The testicular cancer rate = has more=20 than doubled among white men in the past 40 years, but has = only=20 recently begun to increase among black men. The reason for = the=20 racial differences in incidence is not known.

  2. What are the risk factors for = testicular=20 cancer?

    The exact causes of testicular cancer are not known. = However,=20 studies have shown that several factors increase a = man=E2=80=99s chance of=20 developing this disease.

    • Undescended testicle (cryptorchidism): Normally, the = testicles=20 descend from inside the abdomen into the scrotum before = birth.=20 The risk of testicular cancer is increased in males with = a=20 testicle that does not move down into the scrotum. This = risk=20 does not change even after surgery to move the testicle into the scrotum. = The=20 increased risk applies to both testicles.

    • Congenital abnormalities: Men born = with=20 abnormalities of the testicles, penis, or kidneys, as well as those with inguinal hernia = (hernia=20 in the groin area, where the thigh meets the abdomen), = may be at=20 increased risk.=20

    • History of testicular cancer: Men = who have=20 had testicular cancer are at increased risk of = developing cancer=20 in the other testicle.=20

    • Family history of testicular cancer: = The=20 risk for testicular cancer is greater in men whose = brother or=20 father has had the disease.=20

  3. How is testicular cancer = detected? What are=20 symptoms of testicular cancer?

    Most testicular cancers are found by men themselves. = Also,=20 doctors generally examine the testicles during routine = physical=20 exams. Between regular checkups, if a man notices anything = unusual=20 about his testicles, he should talk with his doctor. Men = should=20 see a doctor if they notice any of the following = symptoms:

    • a painless lump or swelling in a testicle=20
    • pain or discomfort in a testicle or in the scrotum=20
    • any enlargement of a testicle or change in the way = it feels=20
    • a feeling of heaviness in the scrotum=20
    • a dull ache in the lower abdomen, back, or groin=20
    • a sudden collection of fluid in the scrotum

    These symptoms can be caused by cancer or by other = conditions.=20 It is important to see a doctor to determine the cause of = any of=20 these symptoms.

  4. How is testicular cancer diagnosed? =

    To help find the cause of symptoms, the doctor = evaluates a=20 man=E2=80=99s general health. The doctor also performs a = physical exam and=20 may order laboratory and diagnostic tests. These tests=20 include:

    • Blood tests that measure the levels = of tumor markers. Tumor markers are substances = often=20 found in higher-than-normal amounts when cancer is = present.=20 Tumor markers such as alpha-fetoprotein (AFP), Beta-human chorionic gonadotropin (=C3=9FHCG), = and lactate dehydrogenase (LDH) may suggest the presence of a testicular = tumor,=20 even if it is too small to be detected by physical exams = or imaging tests.=20

    • Ultrasound, a test in which = high-frequency=20 sound waves are bounced off internal organs and tissues. Their echoes produce a picture called = a sonogram. Ultrasound of the scrotum can show = the=20 presence and size of a mass in the testicle. It is also = helpful=20 in ruling out other conditions, such as swelling due to = infection or a collection of fluid unrelated = to=20 cancer.=20

    • Biopsy (microscopic examination of testicular tissue = by a pathologist) to determine whether cancer is = present.=20 In nearly all cases of suspected cancer, the entire = affected=20 testicle is removed through an incision in the groin. This procedure is = called=20 radical inguinal orchiectomy. In rare cases (for = example, when=20 a man has only one testicle), the surgeon performs an inguinal biopsy, removing = a sample=20 of tissue from the testicle through an incision in the = groin and=20 proceeding with orchiectomy only if the pathologist finds = cancer=20 cells. (The surgeon does not cut = through the=20 scrotum to remove tissue. If the problem is cancer, this = procedure could cause the disease to spread.)=20

    If testicular cancer is found, more tests are needed to = find=20 out if the cancer has spread from the testicle to other = parts of=20 the body. Determining the stage (extent) of the disease helps the doctor = to plan=20 appropriate treatment.

  5. How is testicular cancer treated? What = are the=20 side effects of treatment?

    Although the incidence of testicular cancer has risen = in recent=20 years, more than 95 percent of cases can be cured. = Treatment is=20 more likely to be successful when testicular cancer is = found=20 early. In addition, treatment can often be less aggressive = and may=20 cause fewer side effects.

    Most men with testicular cancer can be cured with = surgery, radiation therapy, and/or chemotherapy. The side effects depend on the = type of=20 treatment and may be different for each person.

    Seminomas and nonseminomas grow and spread differently = and are=20 treated differently. Nonseminomas tend to grow and spread = more=20 quickly; seminomas are more sensitive to radiation. If the tumor contains both seminoma = and=20 nonseminoma cells, it is treated as a nonseminoma. = Treatment also=20 depends on the stage of the cancer, the patient=E2=80=99s = age and general=20 health, and other factors. Treatment is often provided by = a team=20 of specialists, which may include a surgeon, a medical oncologist, and a radiation oncologist.

    The three types of standard treatment are described = below.

    • Surgery to remove the testicle = through an=20 incision in the groin is called a radical inguinal = orchiectomy.=20 Men may be concerned that losing a testicle will affect = their=20 ability to have sexual intercourse or make them sterile (unable to produce children). However, = a man=20 with one healthy testicle can still have a normal erection and produce sperm. Therefore, an = operation to=20 remove one testicle does not make a man impotent (unable to have an erection) and = seldom=20 interferes with fertility (the ability to produce children). = For=20 cosmetic purposes, men can have a prosthesis (an artificial testicle) placed in = the=20 scrotum at the time of their orchiectomy or at any time=20 afterward.=20

      Some of the lymph nodes located deep in the abdomen may = also be=20 removed (lymph node dissection). This type of surgery = does not=20 usually change a man=E2=80=99s ability to have an = erection or an orgasm,=20 but it can cause problems with fertility if it = interferes with=20 ejaculation. Patients may wish to talk with = their=20 doctor about the possibility of removing the lymph nodes = using a=20 special nerve-sparing surgical technique that may = preserve the=20 ability to ejaculate normally.

    • Radiation therapy (also called radiotherapy) uses high-energy rays to kill = cancer=20 cells and shrink tumors. It is a local therapy, meaning that it affects cancer = cells=20 only in the treated areas. External radiation (from a machine outside the = body),=20 aimed at the lymph nodes in the abdomen, is used to = treat=20 seminomas. It is usually given after surgery. Because=20 nonseminomas are less sensitive to radiation, men with = this type=20 of cancer usually do not undergo radiation therapy.=20

      Radiation therapy affects normal as well as cancerous = cells.=20 The side effects of radiation therapy depend mainly on = the=20 treatment dose. Common side effects include fatigue, skin changes at the site where the = treatment=20 is given, loss of appetite, nausea, and diarrhea. Radiation therapy interferes with = sperm=20 production, but many patients regain their fertility = over a=20 period of 1 to 2 years.

    • Chemotherapy is the use of = anticancer drugs to kill cancer cells. When chemotherapy = is given=20 to testicular cancer patients, it is usually given as adjuvant therapy (after surgery) to destroy = cancerous=20 cells that may remain in the body. Chemotherapy may also = be the=20 initial treatment if the cancer is advanced; that is, if = it has=20 spread outside the testicle at the time of the = diagnosis. Most=20 anticancer drugs are given by injection into a vein.=20

      Chemotherapy is a systemic therapy, meaning drugs travel through = the=20 bloodstream and affect normal as well as cancerous cells = throughout the body. The side effects depend largely on = the=20 specific drugs and the doses. Common side effects = include=20 nausea, hair loss, fatigue, diarrhea, vomiting, fever, = chills,=20 coughing/shortness of breath, mouth sores, or skin rash. = Other=20 side effects include dizziness, numbness, loss of = reflexes, or=20 difficulty hearing. Some anticancer drugs also interfere = with=20 sperm production. Although the reduction in sperm count = is=20 permanent for some patients, many others recover their=20 fertility.

      Some men with advanced or recurrent testicular cancer = may=20 undergo treatment with very high doses of chemotherapy. = These=20 high doses of chemotherapy kill cancer cells, but they = also=20 destroy the bone marrow, which makes and stores blood = cells. Such=20 treatment can be given only if patients undergo a bone = marrow=20 transplant. In a transplant, bone marrow stem cells are removed from the patient before = chemotherapy is administered. These cells are frozen = temporarily=20 and then thawed and returned to the patient through a = needle=20 (like a blood transfusion) after the high-dose chemotherapy has been administered.=20

    Men with testicular cancer should discuss their = concerns about=20 sexual function and fertility with their doctor. It is = important=20 to know that men with testicular cancer often have = fertility=20 problems even before their cancer is treated. If a man has = pre-existing fertility problems, or if he is to have = treatment=20 that might lead to infertility, he may want to ask the doctor about = sperm banking (freezing sperm before treatment = for use=20 in the future). This procedure allows some men to have = children=20 even if the treatment causes loss of fertility.

  6. Is follow-up treatment necessary? What = does it=20 involve?

    Regular follow-up exams are extremely important for men = who=20 have been treated for testicular cancer. Like all cancers, = testicular cancer can recur (come back). Men who have had testicular = cancer=20 should see their doctor regularly and should report any = unusual=20 symptoms right away. Follow-up varies for different types = and=20 stages of testicular cancer. Generally, patients are = checked=20 frequently by their doctor and have regular blood tests to = measure=20 tumor marker levels. They also have regular x-rays and computed tomography, also called CT scans or CAT scans (detailed pictures of areas inside the = body=20 created by a computer linked to an x-ray machine). Men who = have=20 had testicular cancer have an increased likelihood of = developing=20 cancer in the remaining testicle. Patients treated with=20 chemotherapy may have an increased risk of certain types = of leukemia, as well as other types of cancer. = Regular=20 follow-up care ensures that changes in health are = discussed and=20 that problems are treated as soon as possible.

  7. Are clinical trials (research studies) available for = men with=20 testicular cancer?

    Yes. Participation in clinical trials is an important treatment option = for=20 many men with testicular cancer. To develop new = treatments, and=20 better ways to use current treatments, the National Cancer = Institute (NCI) is sponsoring clinical trials (research = studies=20 with people) in many hospitals and cancer centers around = the=20 country. Clinical trials are a critical step in the = development of=20 new methods of treatment. Before any new treatment can be=20 recommended for general use, doctors conduct clinical = trials to=20 find out whether the treatment is safe for patients and = effective=20 against the disease.

    People interested in taking part in a clinical trial = should=20 talk with their doctor. Information about clinical trials = is=20 available from the NCI=E2=80=99s Cancer Information = Service (CIS) (see=20 below) at 1=E2=80=93800=E2=80=934=E2=80=93CANCER and in = the NCI booklet Taking Part in=20 Clinical Trials: What Cancer Patients Need To Know, = which can=20 be found at http://www.cancer.gov/publica= tions=20 on the Internet. This booklet describes how research = studies are=20 carried out and explains their possible benefits and = risks.=20 Further information about clinical trials is available at = http://www.cancer.gov/clini= caltrials=20 on the NCI=E2=80=99s Web site. The Web site offers = detailed information=20 about specific ongoing studies by linking to PDQ=C2=AE, the NCI=E2=80=99s comprehensive = cancer information=20 database. The CIS also provides information from = PDQ.

Selected Reference

  1. American Cancer Society, Inc. Cancer Facts and = Figures=20 2005. Atlanta: American Cancer Society, Inc., 2005. = Also=20 available at http= ://www.cancer.org/downloads/STT/CAFF2005f4PWSecured.pdf=20 on the Internet.=20

# # #

Related Resources =

Publications (available at http://www.cancer.gov/publica= tions)

National Cancer Institute (NCI) = Resources

Cancer Information Service = (toll-free)=20
Telephone: 1=E2=80=93800=E2=80=934=E2=80=93CANCER = (1=E2=80=93800=E2=80=93422=E2=80=936237)=20
TTY: 1=E2=80=93800=E2=80=93332=E2=80=938615=20

Online=20
NCI=E2=80=99s Web site: http://www.cancer.gov/
LiveHel= p,=20 NCI=E2=80=99s live online assistance:
https://cisse= cure.nci.nih.gov/livehelp/welcome.asp=20

Back to Top =

3D""
3D""=20
3D""=20
3D""=20
NCI=20 Home | Text-Only Version | Contact = Us | Policies | Accessibility | = FOIA |=20 Site Help |=20 Site = Map=20
3D""=20
A=20 Service of the National Cancer Institute
3D""=20
3D"Department=20 3D"National=20 3DUSA.gov=20
3D""=20
------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/spacer.gif R0lGODlhAQABAIAAAAAAAAAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw== ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/banner_nci_logo_1.gif R0lGODlhdgBRAMQAAMVUVNuUlNaFhbYpKeW0tMpiY/LY1/Xi4e3Kyvrx8bw4OOGnp7EaG9J6eqwJ Cfjs7KkBAacBAf////79/aoFBb9CQv33964REc1vb96enum/vq0PDu/Qz9mOjrAPD74/PyH5BAAA AAAALAAAAAB2AFEAAAX/ICSOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcimKjCJOSFR6 mk6b16fU2oRQsiUuOOssk8A1NHUtopzP6Ki47O5Cu2syu2zG9299V194W3d3bHlUVodvbU9qJleM fjmBW2GNb2SBloNYblxbg3KSlJc6f39aj6krdV6HAA0BAR0ADIehq1OehIinaQ4CEhIBiyUMGhMF DiQaDRAABAAKCgUPGdUAGQcWA24FBwgFHx8BBwkCUhUTGg6MEQ4LBM1SAwYDeAoTAAMdGbZ8palg QYIFAJmaCPBGooIEDg4cgIqwwUCBJxgeXIiwsAMsJx4ISMgAYcCBCRma/1n5R6LBBHVYBkwYUKGB BgEwJ8koQzCBhAQIFeVZmI8KgQwGgkZhYPESgAcUFFhY0IiCMgEDFgSQAE0OBJZSGCAgoHHNAG81 FwjoAGknAAuzfn5AEaEDQycADDjIwMEr0wJTABxwgCCBmg0WEnxYsEHABAxXwELAoGHAA2gjzg5w 0KCAgAqo1j2mQGDCAQV+nBAV4eAZBAUPFExhwKEAqGgHBiS4mAKDhAKMHZRGWAbsBg4AIiD1kNmC 7Aibc9mIAuBxBLES8EVaTaHCgwFOEJBs8peEYAASUKdQkCDDAlwOODiPwjJC3g2vJSjVrAuQaAwi YMfBRiWsFgEBHokAQP8C4AXY1AiCYeANJLQhsMAFbjBwQG5fsBRfA1FwQMAgZ6Fmhio1dPdYZicR gB8JduWjgAEMjOCAAepk+KAUghUwgXootMZBBriIYBkHNf5jnwEXNPHWc5pF8ssM9lm3BWwokUAB UREskAAGDYSJgQEHvEgbbwoe4BCAKdzjXo1RsDOiABmQRsAAeNKUAFUlzecFJjeoCGBgPrE1wkIM 6NYBTox28CUU5UGYGwcHvBLGB0BpUGQUBUiAUwfsESCqqAsYwGCf6unk31tsBkYMZBA4sNU2HCQC AQEc4FdeGU9RgMEEmEWyQAb3FDVFAxI8QCcBDFzQbLPVqRMloDh0ZwH/m2f8+pIAuCKgAQIWBgBA Pd3pB8EFtT3xVESl8WYFAEjS1uApGUigwWl7QHCvB1He1tYLd7A65QISTLBAPxc4sAFNAogDWjwG IECBhoNCseBGHmRgQQcMDOIBBhzkU+we8YiUgarVFSBTBRF5URQOcVqJx1t3CnQuAmwyQMCXAjzA LBUdqDlCBQQg0EGYGQRQlGD5kPFUB68Y4p0BHTxwgAEGaMBBADbTUB1khkQzlUqciFABAF8woA01 FRTFAAD9sPF2AbeQMEADHRxd98QMVFCAykZWcLYCbSvwQTWGF4DBy/+uEOe1UTPwAJJTGtKyHAIQ 56QBfD5CgXv1QFCA/wYZFFCBAgAEIMAGIPezzVywZYBBBggEe6KtNAQssxT1JgePClAMIAE9DRED mFARBFAnBBtwY9saG0wjGC4UOIDLBUBFQMGCwdoBhaVUmr3iCJIf0KSUU4qg8Y/miejnIR0Y89UE D1uKZ141kuDBA8lJIUACG0BR41wgq+F5gDoSoEou4iAHk4RDgRarDKVeJoX4QeADXKFWBApAIzZs gH8QSs8qRmiDDcCtbqpZUeNO1AENQMAl8wKAxEziDkXkDQIZeAB+1MDBIlFhf/3b4ATy94NNqG8Z XauC5BByFq4pyB3bG4kh8naBA5CEFIUQnV6i4IYLgDBWIvKKD1SVPP8kAi8PddFAHXKYPxnWwzfB WpTwjoeFKwhGABiYnWy82ACaLEBT6UMFGjKwuxYwZT/AeuKL6iIB0HwFK2asAm4w8Lc+RqCKBGgA AvTDByBcpwIfqACcIDCMKw7whRz4QhQWUKZoIOAdTiDNqeQoAVhJIWpOGFPoRLA/ZlQogEO4xwRC FrCHAJMuhvDAhkYlKgMswz41vEMVB7QWDRHADiOoQ8NwYQYvBkUqOQlCBHyTICdoqJGBLAEG1GS4 w5UDAZWqwCvxYJmkQW0rxtICFLaJhw/2bzLOSeJ0ROAbJ5ZhGNdMgRxuBJMSOIQarxRjT6SVAOKR gQH8JIE3p0CAA/j/sAd3KCgeqvibLKrqGhQkAQc0AIBo4qFTMEHPhRIBgJqYzwzV+6IU0KWB82FR B79yIhY+YIGDkJAKtIGIlAi5AAQQUQuLihMHOLA4PClAAAjYQAAsQI5q5PEstoOAzgggGyAU9HeC AVYdwNBSpTzigifkpq2eap9aHK0BAkAN6v4GN5UNoKbYjEZQTJGGyRQjHokK3QBKgxxuOsF6d0xU niSLJzg5a2J5quwAKGu9Jllvh7FiwIs2y4BEbYCym3HWBqw3ANBWwrAeuQACnjmKCpSKA8OiRdEM kAE6CSBMIlkAJRtwMAZYgFnKC1PD0hGmAEzDZ7s0UgKQRDQ8EjeB/8rVACWBBYAClO6ULwhqBSWQ GxMwYEzAmYYCanQ+s8XmCR07gACstwbakaC0z9AJYUgySuZNqA0DwGCDKCJQGYgXAgEojEdJQYHF kjKIJniKI8vggAMk6AlN1QIFaocJwnTuT8ZNFRQEjIWj7iSXxVDfZ+z10ddcMwMgeiteHuBIG1l4 FQvoCwkIg5k+eDgLJcoFiVGUA5HikC2+ORkJFHDNpzQNmxIuQYUvPIIM7xgBDZ2Ch80b0KFKgHEF joGRAeI/TymCycwjC3G0ByEaS/nGJbCyjTichfh8OEBdbsIHZvIL8K5gzAmSR0m/wGRIiaQD7+hC lHcMZxLIWQo8Fv8jGO8s1jxLYc8N6G4DKkDkGgA6Cq3hpIuz6ZiQrWHRNqayCB4dKywDY9JcNlEU MCiAv33GB4C+L5n0SgA+bG9DREQ1axpdZQRIWTy+2DIyLE0BEpv4Bp+GRUmslqhrXoGoYIuGmxmt agg8OjzWPjalQyyUIWdxB7nmhXcQIA003urCwo4VsVdt7DgPBgpaxm0WyO0IZx8CfDbI9Vurc4AF rHUEBBAAdbadahOwOhqiPoOF9m3pCBAkf6WYDooNBRCdCJEAHvgndAwApKfMRcsWzkJTJWGVDira irFmRAUSQFdJ10AeE0AAhkR1GzZ0wEUa6IDIFtAAT3QqiFDA3nj/QH2vnkOqVH0cgHczkAAN4HvW 5jLPbz5wv4bmAKM4aW2YfJpFB7DsbWBqwMkhXYCAmOW3sDRS2FdBge7MIgAYUMAAfnu+QQCg1pby jJjA5C5AiPF31PLeMV4dtj9lfIR6uHpqSvwEgOfurYFsvCQTgsx05gvyQqkjSHkhCe3x4XaWCKzN Ux+Gx5NQVTJGxQSIMfsJ1J72t5897YnB+97fvve7tz3vfx/8ghnf+Ln3ve6F73veHyD0abCA7oE/ /OIvv/rDnz71r8987VN/998nPvCFP/sDdDoGESiI97/P/va7//3wjz/7df/8HfiE+fLPv/73z3/a P9/PCiV9yNd/YwRYgAZIXjsQAet3gAzYgO5XKZ7EBBI4gRQYPgmoCABYgTvxbABDCBmogS0wBiA4 giRYgiZ4giiYgiq4gizYgisoeS4oSLDnAjAYg7lzdTUIM4XgZz8FCa43emRURziIby0QAgA7 ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/banner_nci_logo_2.gif R0lGODlhOwEpAMQAAKkBAf///9SAgOrAwL9CQq4REbQiIt+goPrw8MlhYfXg4NqQkLgvL+/Q0MRQ UOSxsM1yctWAgcBAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAA AAAALAAAAAA7ASkAAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRK rVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh34DA4iMVAIBi1AB ATIMBAICCQQGjS2PkWYDkwkpnzqmkpQuBgsIk6+TCm2iAkaooZMIBSi3LwUJtSQJAwtRky4JrpOK ig3HbLQ+vw8lw8UjBhDXNNmkR6KTwSa9LgSQWc8rB7EJuyS/swHiO+aqKuQxj/NEogqTnOPOxTAH ykq6FAkmPXBHJ1qPeizwwdCHhJY/agELlhN45eCJAq40znHIA+IKiS8o/36TV49AxhIOBDA74A2A AUzrFGASwOlSzREODjBbwGBcsAQPFNE8kU2oIp4lPJpY8A9GAQcLZroUBpWA0wEQGJZgIFPRA6hA nT74CcAnAAZCMZ5weLNWAQhJBxzYSiLbTAgG6q6Th6lnpraY+u00zJeE20syIe18h1RpYxvRHgRo 8HKEMlgC64EO4LIXA2ejF5KYVAA1rAMlIIwOgMDBansoXMGG8fk1CVFeRysAOKKA5tHBCoCD1YCh 7AEOYKVwWGASA3+gd4sg0DucaNClzz2aHX6fCFPjR4+4Plo7Znk2J0Eo0SvA2qJkw9nEGUBnYQC3 GOAKAgIUFdxmt4nygP9LDBw3jwAKLEBAAVc5o8sIUpHAwCSXsRDAAQ4YSFUANSm4mQMF3BTSO6jt lWJQ3qBWoAHJILjdZrphMh18IkzizF5tHecNSJCgaAABCyQgWDj/mQKZYk3ySN85T0qmo00DKplf ANvU4NAjF47QC3Fi2nijRreIgkBRwujXo5sjaCYLNiYQWVOGIySE2yomrAMKOM2REF0AbAKgZofn WafhKDcqugJJr7AlCmcARBfmCSaVWRA5Kk25qZQi9COWbAGQOQN1rnSJ0noHEeSpCBuSeMI6YcZi QqyFoqCZOHgmOucNmYJjKgD+zNcWo7mBKsI6lNbj3o68cgTUM6seu2f/L5wqm+in88TaoT/mxUCS nsRV+6Zj0gIoEJgoGDCJbQDAeRuiJHTaq7oizRDrCJOesOuy/aVQj1giDNportBiKGsJ1RFqLb3W vqrplOFiC+ojlJZAVb4wkGQoRxIRANl46KIpkIIpgPsmov50eCQwkUV7T8A0EBATJumI0mWZwTiz c71mLupwpo9KyeEJRwPQ4rARA/2pyRVL2+nHPwMgGwI3eFwPvL0QcJx6I7jqdKja8mvfynORVhyE s8mM0L0oOLAcaGZHHQyyJ4DJzN7guGROxkW7bULSyr1ygKlE4zs20FFz+1t/fDcDNwseA5DTtmX6 uMBOraaLSuWPR5J0/wnAiWAAdgiclZjRe5ZQD8LqvNLA5jjbA7q6d6vNy2zgHcuxCZC2jnbYy82T uMVQ5y01qHPznrWyAsKHSj0NmNq5yZHcTvZuoz++FTjG8qzwCqm+oOcDZDZct/K5h4v5CmJTzjoK 3W8nY9geIU+x8o6vDwToYCoAKnJCMPXhD3si0MzvXJE7RJXOXQEI3wioIjgU0IpgO/oV/mxXNpWI 4lkkuBoL4he48SFNdyY4jjuOtzyTVc1PjCOBZuTig9v54wCf45IJDHZAiZEKg9ZiU/3I5jfWAG9+ KoAgDVXAQBPoyX/7AwBVLuW6IVbxd6RD4uBQWAIIboWFT5NYCfzRv/9EUZEHtxuUKLKnwxIMBl2A U1x82pjFX1mxdAPrIpwmNx4QnkBlWeSg3UynkJSlywQkVEHw6MfFviQNjIvLE20IVo9PuSdW7sOB 9pYTiQu2qXOliuR4JFiAwcArXo0k4hzn0Zo9Cq9PPjqlMOLUn1G9AooxFMGIDgDEPjqxhy1Y5Ald YgCCDcYdsSJT1ybpyA9pSBmf0uDHFlYcWdJAexAUSKwQQLtJiaJQDWuAADYnxwT6CBMLwI577qi7 wQwAnaniyOR0+QoEEEMAQnHFBv0jAGeAA5fiE0Er+0O7AyjAWIOJEE70eSYXCHOL4VEd2+gIAFfo ZAHFGNM5k0RPKw2sxjQKwScpCoAdcWJCgZosW0dB4YDu8LJ0IyDVMsp5nu4owJrs3IpxQHPT+M3T dIMRjjC6s4CGAeR2UwNQd6QkgKX+KpEJO9cwrTYaAlUDFosgx4gmsY2t5sIBiQwqj0o5Gz8a4WZK UgFZBLAJFRRgZBB7AY0wEVcZSAACOwlRndDKtJphIgIQuMxb89pXIRjgZgJA0QnW2tYUMFYsc00s EIEC2An1BbGWvUEIAAA7 ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/banner_nci_logo_3.gif R0lGODlh0QAoAMQAAKkBAacBAf///79CQtSAgOrAwPrw8LgvL64REbQiIs1ycslhYe/Q0OSxsPXg 4MRQUN+goNqQkL29vaoFBd2bnMBAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAA AAAALAAAAADRACgAAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp+qAEA6 ClBJgYkVirVuueCweEwum8/otLo1SIwQA4RpQE/BD6PEwDUg5CIRJXo0BAtMBw4CfiMHeCNtMAWG JQcFLhSGio8Ce28MAqCLc6BuAAQCdhGOpzkFliSsLgcQIwKvCg8ruDsNBg+lIq4kmi/ED7kAA6gt EgoAxMmcJAoCDnSdo7YisSfK2DrCsMst3MOiKNA44STrz+csxAWLyi7N7pvfp8gpygXSsQMgOHDg J8InBpYWvEoAwYABCHIq9THQwNGDXgyQtTO1rMDEigAONLBVKVGBQJIU/1YrcEDhCEAqHbAE8ODT TAQjZ5J44I+Bs0oOJbF7JYKYgk8gASgYycCRIqAyDyhj+FAOCnvQvJFQJgACsFEDZHIUAaHBUgEt IXT1wwqBAwMLFBhgEM1AIYoiGkBYwMCAnI2xBNhdYMDSyAaqCPgr5K6PLQIJuLlyLC/BAwENavo9 rGqnrQUjIRMYSOBbAYIEUmui1oCwAxEPjxooKlomZGVwT70jgVWU1q2JfKHwtkDAAm5wLvv5zar4 JOfKaAFQm8fxHsDLuoqIgKqAAWzciBGT/Cre65ACeH43wcCB1b7BiI7wB6q+HwZ0aUoDoIc7nnjz GCcCQilgJV0034zg2v9w0rQXC3f2IbgNKsgposwkbdEHynXyjfUMhqg8YIAtcoS3yHjjhBNPfaEM MGIBVhXVwAixbARAO5qwuOEBn9S3B4AiTBVfgc44kJ9S+5kwEoN7KJMIAMWduNx+rFDjyAECKFAB lahwl4tW2BXVSSwInBKIibSJQE0pYt1z45FvnHIgAEaOQN2NHeJpDp0zkjDSHpf9uIg8QaaY5wj2 6GaZAecdx58CA4j4Wh9f/UYfkg2UqYkyDCSgKX8CMIAAAn3pwSUA3EWAkzRhPjNmiAmwxpECbhDj 0AGmOnPKK7dGlmVIfvwiK42/RjdkCTj6oZYzDxgykgKkShOPAbjSc+z/CfYgoCG1waBCDSjcnvLN bwmAAoBb4BLTo2MiEAauIcyh4iIon3BYQmCv3gguHlxZQgyE94ECAYGohqJtfbPRxy0JaoEC47Xz yafJwQ7rl66g27VoKJGM1HECHAnCQEeMQYYMMskfe1yDVDHq8ZUILAf5ckhxiKBHzTSjbPMAjqys MsgpxPzCAz2vYfTRSCet9NJMN+3001BHLfXUVFdt9dVYZ6311lx37fXXYIct9thkl2322Winrfba bE/hxRVtR/H23HTXbffdeOet995bwF0F34AHLvjghNPt9heFJ6744ow37vjjhIt9t9pUeDGFCJUP YTcSc4swQQmWnyBFFOZwj75C5phjkULgq6d+uN6qWxECADs= ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/banner_nci_logo_4.gif R0lGODlhagAoAMQAAKkBAacBAf///9SAgPrw8L9CQurAwK4REbgvL9+goMlhYeSxsO/Q0NqQkM1y cvXg4LQiIsRQUNWAgcBAQKoFBQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAA AAAALAAAAABqACgAAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wGBg6BtSAickYKgMOp/QqHRK rVqv2Kx2y401EqKCwSFyLBYNkcIQEX0NCrcBIYKTBgyCAYBoPAhpAGsIBoAjeHoABwkEgAeCDQoP dCIICwIMDXt8CwQPCQcHY5VzJgMCEAAJmCKfnSIMAmAHAg4PDCIEtXwCbSKnCwoDAHgODbunDAqX ccfBw4XCAsPJA6mKjRGXAtgE0nsMD24EJwgCcQSXEOYRCgIIELLkEajHB/QLuAPkI4klBQUIgDlV QNE0AAI28SKjStypa2UEFARggJsDib/eXaTzCcWDBQUEHCDgwAE5WhJs/8WLkAAXuwQL6EFgAGbE wUMCciYkxk3EtJDDwujUSYwfzqOXRoQsQKsBvYkmGgDCBdNAzXwLwGQi2SrBAzLTepGQNcLcgkcM 9pyyOaCp0nMlBijMeG0Vz0cAngJY8EkcCnNc3cEVlLONVFTjEHciB2FAwUsFAWI64E5tT4TQCEQG 4AkB5YJy1QwLyWDCRW4hQc0k8MidoRQP3hkUKYJWT3N+eeEivAAAUEUVcwKIJaCRZbaKiHNDoCsn tU0VM8pKSjgnAUqcEWdBUOAaQLwruIMHiD1FKkYjDgDsksWA41M12XPZJhC8/Pv48+vfz7+///8A BijggAQWaOCBCCao4CaCUjDh4IMQRijhhBRWaOGFGDrI4IYEZujhhyCGKOKIJJZo4ochAAA7 ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/ntpagetag.gif?js=0 R0lGODlhAQABALMNAAAAAIAAAACAAICAAAAAgIAAgACAgICAgMDAwP8AAAD/AP//AAAA//8A/wD/ /////yH5BAEAAA0ALAAAAAABAAEAQAQCsEUAOw== ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/main-search.gif R0lGODlhMAAOAPQAAEopKOXg4PLw8Fc5OIt2dWRIR3FXVrGjo6SUlL6zstjR0X5mZpiFhMvCwv// /z0aGf///wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAEA ABAALAAAAAAwAA4AAAWwIPSMZGmeaKo+4uq+cCzPKxIExNM4PDMSjgOJJ0gURgyFozFw+HQNF7AA GEBNioAAMHIOAokHQpCjOkeN6IrhyKHVo2ah3WUAAgfAefhMvw4OAQY6PA6DCFEKaoUNAAaGJYU8 cCsDCgJXJAIBDQEOVk4Ln01udW8uA1QJAZkPQAawAggPZ7I6AgsPA3p9lCgFng1HOz0NYSMHW2fJ AAAMO8J7fjTU1dbX2NkqLdrWECEAOw== ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/nav_home_off.gif R0lGODlhWQAXAMQAAP7+/Xd1aWhlVdbW0q6tp5GOhevq6GdkWPb182ZkVZCQhoaFeKWjm7Ctp8TB vLi3stjWz2llXGxkWI+PhOHh3czLxpqYkPn187i4r2hkWWhmWWlmV2hkWGllWv///2llWSH5BAAA AAAALAAAAABZABcAAAX/oASMXmmeaKqubOu+5Qh4gOFxX9d9fIfjnx9vSCwaj8ikcsnJcDSC2WeT 2/WEwSBny91GJBLtckwuaz6Rj0YjpVqJu8hm+5F0Mr6cQLKZC3I4HVRoGwIaPlQbaX9Zd2dPVTpZ QGUdGiVTOUWWEglzGhwbBwcCHRJOB2sZYAc+gh8CGX1BohEceXQ4aRlFoXh4d3lLlphuRk28dgcf sh8HchqFt5lcPIMbHQICEQeFoME6OzpOk3hEHGHDlx6Zb0McAlRgHa2lPKURX6GG0zjd/lMSWDmw hd4ZK5QaWUE4hhg7Y0R4paojYZ8yKgoKBOCRwRYzZhwigIKVqs8zgogi//EKMk5Nhwi/IKkrpsnI AA8FnrEpwEMDAQQzACzQAIEATF6WAEywVgBAtIrxbo2LIAjdGzs4wLBsuK7dkQEIIGiQEEGpqAcX GAQ4MGHNAALfeCRQukyDAg9nnIlaxjLaGh0alqV78kzSzIc1h9gZ8AABAwkCcHYIAMDCqEEZihKE FcrDBIIbCniY86GBDQqWNyx4i8CxBRsP4EVgYGPAgnRKHHolsiHDW9rRcB4gYMBUmFMRih7KkBcA gYwFCADYQ+ACT+kBIjR1EICABwgBFlTWjqBABwcDEnCl6Y7jgAYHDBDYAKCAzwGHSo31TWDLhjMZ 0CADDVBQMF8fA2AQmv8HAXBwgAcMxFMUBw48IAAHlG20xBrs9dJBUQIUcAFlBWRAWzeF9NHBW4VA VghO0XQwAQCwKDUFBwTgJ5oiHXg2x3tEmTACTxt2BdE7H7wnwAEQPACAAhIE4IEFGayyCgdvoUTQ TodI0BRZBjBgjQMOaLDjH0rh8FYGFSi4DXNjcIhYe7a8Z4t4wmmAgWMBZLBAAETBh04d9BWQABgK ACAHART0uQACE4QIAB+XQCkBiwwgsAAsC/ClhJy7DYEHBA3gIYADSsHkE1AzFMABqaT1kQCMU4im XgAVIHATAXWIpk0EHkC5wVvOODmAARWkcVio1vgDDxUezROiRn7JwcuCFxJAEVIT3YQhQAAKrPXH E3KQZgkU20xWwFCMJGHHBx2eY0deaFAaDjY58GGJIT6EEY1VFd0RkgaroIHDWKfcYc2VPJyiyBLv YlLGxBRXbDE9EjwToFNDhGPxxyBbPFZvPQKwkhHhpKzyyiy37PLLMLvsDB940NCuxyHnrLO74wIQ AgA7 ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/nav_cancer_topics_on.gif R0lGODlhdAAXAMQAALm3svX19JGOhsPBvXNvZYeEe316cOHg3uvq6aWjnM3MyJuYka+tp9fW02ll Wr29vf///wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAA AAAALAAAAAB0ABcAAAX/ICSOZGmeaKqubOuuTyzPdG3feK7vfJ9Dj5dwSCwaUcHgcclsLpPOqHR6 glKv2Ccwy+26rK5GI+ClDhpT8ApAcLgP5ZHATXcMGYP0lsUgDMhocSIHYg4AYoIpaigIDgomAAYO BnkQBwIDkgtklgsOBHAHBZOPEAMJCQ6BJaojkQ4FpZcDbQmceIOeoBCpuy+LJ5EnAwgQAA6ADpsI BgAQAQa2AdMEzrRkx86crIFsaMfFDcoBCAUMIgLa0dMBkeRDwJACKAGFaOLFxvMKBNsDBSMK5GGj ohWEAs7QncMnIhM6Z/y2sYEDb48KhyZSCZhzz44IAPNAkjhWx5nIFAYNwuqDIG5ESwjpVo4I4Omc kHglGpUakYlTq5crMX4EWOIkCoOURqBi6SAfrYemDJho4OemRRV9/lhCAIDogJ8eVwao+qxRJYpG TxjsSuYAgY4JBSSAOrbSNBEIrSphwYZOA2YGBBQo0NHVPAj8BqOhNZjAx8NHA9EkMCehuAUFDBjg FBMxAcVdM29rgROFmHwsKbZooJrlKiIIxri0Q0gF60Gvv1xNhAVol9K8nVyKAzy4cSPFjyv/BcSH 8+fQo0vHASEEADs= ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/nav_clinical_trials_off.gif R0lGODlhcAAXAMQAAP7+/a6spNfW0nx6b2hlVpGOhWdkWK+tp2ZkVevq6JqYj4eEeri4rKWjm8PB vNfXz/b08+Hg3c3Lxrq3sGhlXOLf2o+PhGtlWXNvY2hmWWhkWWlmV2hkWGllWv///2llWSH5BAAA AAAALAAAAABwABcAAAX/oAd4ImmeaKqubOu+cFwiHWdk3KfvX5Z1PF5ONwwaj8acUkhEOpuf4tFA rVI/G8Dv0tkgOeCLWDwsSp9EsFodbS/BzbV8XobSz7tMluc9bjgEHGIbF1E1Xh03Nx0abR2PQDiM ho0cehoUk0A5NRoZNIFAiR1cngZEGVxDBps1aDobezt9RhRknz4ajF2jRUA6GsFRHBqsbjWixUAU OowbCB8Ekx+7GhfSSkO/px+scJwctEGxAHxOG0CxWHAaBOhlj7qPWM+PSvK61BwdBN0UlpwOfcjE qhEBd0Qg/dqXj9sOQYWceDB3RMMGVmMubCCQwSI6AxupzTtWBFqGG20s/4KUZ0AXoItAQulg1cqV EAoUXE7iNg3JxFlInG3IsMDCAIsNJrAq0IAATZc6KDDtYiDTsUbNCExo4OUCMa8nfYB0NynAUUjN PmhIGk5avjZOgPyEhUSaAQUJAOg9kOGAAB0NGExSckGDpaTcAFETw6if2g0CAvSLRWEECb0CeFp7 sEBME1IdAjzogGBjP0h4dsilaORCBgUADgzYMGAAAb/XfMTq4ENSj5P2AHVE5IMZEAEHNqjsUKDA AQAFLCwYmsFdMYiWelPzq4fKJHxBP8zFgmQDhQRKcaDbEEAA0gkcKAhoEAFAhOkZEBvA4AACgAYc DCABCRJgkAhyP+zDUf8GBQDwTwcNOOAAdBtwllN/HtxHA3cZBOBfA3r0g5VPFJmh1gIADECKV134 pZaL4iUwAAYSSCCIX6xIEMEABqi4gAL7JcCADsh1w1siHzQIUl8eBHABBht4UAABFwSAwQU6AuEX AQt4sAAGGLQzSnjj/QHXMARY4EFpJy3Z3gcX+IXOfzg0SIhoT0qpHDo6LFCAA5l9gJwBNvxQQwEe WGLAARCoBaeUF9wwgAXPnbJllw1gYY0u4vDQRZlpNHHBAB7MdlEsiwoQzpYdeGABF4gS4lcHFji4 URcWJJCAALv+UeRH5MVayJYncQBdgAJAIEAEHsQy6wbPCYABnBY51sz/L5+y9hBIHKBniyoazMqB nFkUQAiiqbSXwQApeiVGAgF4siVkfNEQDTqIwvkBudRAl4EDEthSK5WiUXDQABU4UB1p6oiEbZTm rJHHXbENsO4C47rXgV+N+KsBoghw0J5GDzjgWpgQKPBkBZllMCgjWH3sgUV9CYAAlRdISYAE8H3g wMz7CkCAgQhMIAFI1Fh07cOgJiEPXiMAEAB7D7AimnIUbtCgDrhxsEAFu0oWbQIOPEDNAweQ0cU+ tfLzgWhdiAHdBwpAEEHCDgZNQAG7QlCARWAwo9ovUTQ9jBrXzFTUAg9mQI0PpMTCkDR/JNJRB0WJ 0WMBYeLQgzUavRQOjQWEFMbMUN1cYAsGRlEXTTDrcq5cSk5k8NMgdQyzsEWCR77ikZGqkglVokjT ESw1ZIKO5dQ4fI0tv6TixT43eAZnIbzZgsUvFjESkRE+eOB4KtlA8cr56Kev/vpoeHCK9OzHL//8 9AdhLA6Om3mmwwr17///AAygAAdIwAIC8FH4C0f9FsjABhrhEQAIAQA7 ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/nav_cancer_statistics_off.gif R0lGODlhggAXAMQAANjWz3JvZpGPhrCtpmhmWv/9/WViVYiFfGZjWOzq5GxpXeTi2/799sjGwKKg l2hnVPXz7fj19ODe2GpoVb68tX16cGpmWmhkWWllWmhkWGxjWmlmVWhlVmlmV////2llWSH5BAAA AAAALAAAAACCABcAAAX/YOGNXiGSaHqmbOuia/nOYyyT9k3v7GRlGMtn+MkQi0TjcclsOolC4XOa rGIuFozymDEqLIiv0YCQUpeETuHx4bSdBk5HwYl3zvimxfArGj4IXQZ8e04IRRaJfxllGX+AHwZG YJKAhH+PeR9pGwUTHxdvTYMTChtxBEMYGKqhoIirSEZbH6tuoYUZPwYXbpFlGI9CWBcYZYRgRQhB ZR2HgUOORgiXhaustEwYHQQPnq++TAqgF1gdHEbF0Uy6tVfvsetK59QKjollH+dbSkrGjAaMReHj qEOHcmASKriCZVmyKtmObOv2LVS4JQruNJvA4UofJKuKJVIXTYouJRaw/2zjgCAMI3wWOnDUFbLY qmkZLiDowOeCgoA66Qk5pGtcP13QELlyMtHbJ4twwGBQ0LJDkHbrkCD68HEWKINGVjkTMoZqGQsc qPK5Ey0n2gwKLuhKyCslhgkduvy0F0mvpIQph5Bkys0pOCeMFFQ4cIDAIcFXkoR9R8RmuchtDbrZ IzWAAAE8FVDlumVVSmoB+GCoMOD0Tw6nU4JxIOBlFkBY2n1s0rSiqCYHAIhg0GBhBrDxuLpTHkUr qN13bwUx4AACAwYDfh4YcE0WICECHOALrvM1Z9pkKTj4+SPMTjcRtRX2ffFIBQgAKigIcMBdBgLF hJVEGhwAmByABsoBYP87fISRQHYBVGCAAgMA0E9KBvJUIXtynTPhBMcAMEBu8P1kWjoEYJAKEIRR 9NRvSzQgQUsmrtYAAx40EMBPADggAQMSHKBiAA1EwIADxlAQQQE6EkCAiAkAsJdOR4bRCwAJRNCj BRU0YAIAATyApZYOEBBcigNY50BwEER5AALqEaDAATdGIGSaRxrQgRlL9DZBZPUREUGZdPB0wQEO cBBAAhRM6EECFRBZnAUNLKBfBQQMYGkAEgzAAQcFQBqAPjxRCsEAAWAhgIyMGXCAAPs9aIAAFCwg QAUXCFCAmQwcEMCvAixAgQABPDmAAYvquN8Bvf7KXotOlQPjEQzAygf/bDmZuSoAGIDqQBgCeGBB AAVYawEBCQjgpAAJAFgAd0KUuscADCxwwBcVzjTHqw1ImSkAE866xgEFfCsaAiL+NIGIFzgQQQDu EVxmPU/4KVe3TiTgwAWO8dQBu1FGecEG1X4hAAMEnNxSWgicYMKuGJTLh550HBPAAtwaUOEyCoCM Jbf/0sGBrhtcQC+YcCWsAcID/AvGTxkM4AGYpULriRYYNyFjqnLC9qBjFW5TbksnG1ABA/ptUGAE AjzwwEEPZFDuHj8Z9AfZDMRV4S4PUrXhvwjApusEjlXAqDEiIqBBByIS4EACyBpAABgVLNDAhHxK xM0EBWxgzLREVBBB/wONeZYBBA4gKwEAgZeswckKaABAAzsFYEGtARB+wITVnoVIBuoGUGtOmoZh AOoI3AyATpraY8HgxcJZnAIAUHCBBhY0HsCpcTgrfSnx1bI5fYYEdx0DAFhwNKNSdtD78wwIccAC C3R6QQAAaBnBAIxU+0cxF4iDBEQAgd114D4LGAACBlAALPWrFAhUoK4ewC4AQEAAp3AA+gSAARGR 4XH0+0yUqkUArMiHIufoVqCG0J7FcFBFFSCWk3TiJJpIyzGvmhAjYliBnfwJNio5C/DUhYAJeM4z O0JADFOlAQOACInv6MADljgyJ8VQA5sgQFr4IIDGcCCGX8jLUpgwn69Svc1JaEzjf+SUxjYOAY1Z TEUbOeYkFbXxjm1kBRq54SQ+pqiEdZycHQMZRzriMY9pHKQbC+QNZmwgA5+KpCQnSclKWvKSmMyk JjfJyU7ChiUEKIACAJQWg5jylKhMpSpXycpWuvKVsIylLJ1BlQBEIHCpuZ4GdsnLXvryl8AMpjCH ScxiGvOYx9xDAAtggQ0oYAIj24A0p0nNalrzmtjMpja3yc1uetObUqxDAUIAADs= ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/nav_research_funding_off.gif R0lGODlhmQAXAMQAAG1rXZWSif7+/bKwqe3r6aimmtjX025rYXd1aoqJfvX083BpXuLh3sXDv21q W6Ohmbu5s7Guq4F/c3FrX25sX/j082pqXammoM/NyW5rWn99dG1pXm1pXW5qX////25qXiH5BAAA AAAALAAAAACZABcAAAX/oOCJXmmeaKqubOu+cCzPrCAKH7ABB89/wKBwSCwaj8gh57MENoXPpNQ5 rRo7nJ5FkMkcOuBOcGEtm5HLNDPKiZ6p6nja/QYCwjjAXUzU5w4OZHxMhB0bQYdgOkwUGwcbYhRp HQAcfJA5H4eaHQdMB0tilh+igIV7d0Cbo02Pj2IAjZ4ZPG2iYEG4pIO7VxmGHx6ZukJ7pnuHobiO YJiSToamUEAOpECSpW2YpIdfGc9fhpULWQCa1kFuS8+7HBQTCxsbCwuUGxSdkLxKSBsOuMKAEAvS 6Jk8Ck7w2aHyAeGueGHuGeLTDN8lCvRANbH0xUElT/+YOJKnh4IFPTo6/0wgaGniK0hZQAHI+CEQ hUqasoChhynUyH25RnUI2GuIOUvuZDakQ6iJOVgOqoFBCKDanUMOJHmixGQCKziiNqxzl4ND1kc0 iVE6+uHLDg73qt3sIEneOrYbmSIRM5TvQCALGllotCMDJ74HEHai+HfXtpa6cFEykECfI1X32iII gADUsyX6KgFTnI5JGGCOlCUwADfABUiOErcVyyP1M6BB2wYMQ8TQCAEKGiDYhcUPnyXmvmSit6CH TnqwMHXiUGmDgAAfyMEdVimAAgMKArD1tyGAjREDKHi8jIyQKnigNJnXUQDCGk9Lv6i5TeYKkANE NXaTAAO4VkEDj1Cng/9oCr5VkTmBkYQTcn58pMMEDngQgCtHadUGBhBYAIEBfGXXnHkBpChBQ7hk wQhKY/yDUgAe6NHDbOb8IJBHetyjVy6kBAiUGBr+MoABeiCAgQcKDKBgA0wmAICSwA1wzwYNKCAA AwmYdEEDDVznwAMMeEBAYAQysGVlnmBECpgAYNAAaI3oYd4OlBxwAQRVdQBBAR2sdgEBAmCAQBsP EMrAAALosacFB0AwAAYCEFDARxBoCeYFfhzBlweNBfGFBwUWUMEDgBggXALhbRABAQhIQI6qCCRQ gXgADNAZBgx8kMEApFpQqwARACCBP5VKoCQGGXhFTyUSKMCAAQjc4ab/OSimiIADR2pygAFO0mio BAQMsEC0EWzAqjAAREAiAAZcl6sCQAxQQQIWQDnAVkNa0xduY5QgQgTqSSDAth9A0AAFAyggZQYa eIDADgo74oAEAUQggFcNyzgiQjp5wOkBNDpCz0obQDCCBBRgUEBc2dF43oZHrgPuAjRKcMABRy4w aFW5erBDz/A2YPF1HTBwgQUOWFCuQP1+GqodFFyXMAHYjqC1ARtQyafMJhhAgQbgGVBmFu565QC4 VXnFgYYd4AxqIEwsMACsDTCgwXXqTWDBB+bZ05C7XnwALgeBw3VkB0f6cGeuBjQHLnwaBhMAFhOA m0jUQQJsh3UBdK3A/wUUJHBwUgdAWp4CBZhebRuGNYABJObl0LPfYFJwADkZWI2zAB7VtQG4HSDA gAIE/B1PI3c+8oEFjZuzKADmgcKzAR8MykFgFwjNwZETDG+uYVazrt4G5VLSWIl9IdHcdQtkkHcs BDRATqwZIJCBA4seUD8oCNBAB0DkACx5gDpHeoZ3pPQBBEzAdzSqTUMO0IB3icsC28MGjW6ihwwU QGIWME8ESAYqHTROAiIrnprE4i64EM8SGuIABAiggUgRyC+98RdR/HOdlaAQOwkgAAHilYAFRIAB DICVBYI4RAEkgAMPqAASw6SHI0FqAdwSgAGw1oHrfINGu5uJIzQgRP8DVMBeDcBCVjpQMkPs4AMM qIDZFgU4AXQgKkfKwAIKoMX6gYoD7gKC5n7BNwSEqQIjslJRcjgUgRjhWaL5T1YAkADO6JGS4vHC SSpZrTtuRgKUqMcjEBK/rgUAlKm7ivqaMAG6OCBFS3AASCggiSzAIx5kOEACKlOVHmDkSrTEEMYQ wBVL1FIWMzkJGDzSlnJBBGCfcmQRZvIK6qyFHjmYiSUC4YkFLGIUd0AJdbC4nLZoQg9xm4k5NtEI wDwhJYOIm9/qQYrm5CiX9ZjJOduSI1/1JztC8CYg5pIiHjRMAzmYmkBqtJjTOPShEI2oRCdK0Ypa 9KIYjegEABA+MtlRwAABUI9FHkqKqwgDOhCtg0pXytKWQg1zLdlBLHa2iUfCBQAHXEArU+rSnvr0 p0SQhxAWYxrPSLQ51KlRp4DK1Kb+9DQ6OQQzMqEXlMhDACEAADs= ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/nav_news_off.gif R0lGODlhPgAXAMQAAHZzZ5GPhv/+/a2tp9bW0uvq6GhlVsPBuoaEeM7Mx2dkWPX19GdjV2pmWmhm WmxlWt/h22tlV6+tpbi3sqShm2hlXGpjWeDg3tbWzWhmWWhkWWhkWGlmV2llWv///2llWSH5BAAA AAAALAAAAAA+ABcAAAX/oOCJXmmeaKqubGtmyrd9dG3feK7v/JcJilhvSCzmFAJaZ9f4cDScDifT 2GQMnOpU01kqm1Vag7tpdGYfb86j3Gm0jE98053NFOhbZ1wvL8s0dDtsaTscDA9SBg0MVWhWGR9N M11dgZKXfG06hGo4WXJTBjIcHAYbGhuUlh9cH1itHRqBdGc9nTwKDQ1BixUbjY8KHQ8ykYkyaW+s acGDmzkcAQIEDg0ZEhi6DKYcgqMfDk6yXg0WyDVVTZzQOAYBHgsBBg4DGA2jDgowMg7idOL20Mjg oEIFcYWSsUuYwwK8AQUiNJBAwIABAAkELBggkUCAcxQ36DsQAAAGAQUc/0RixBAHLh0KpmUoQOED RR8EDgBAIC9CggkNIhS4QIEBAAEYE3QAAIiOqxwdXubIAM8AhQUAKDY4CsBChwkHGlCIiACChAMR KFx4kAACgAYPLBjIsIEDDw+RPN2ImUQBgQEDCDSYJqAwta1IASMoYCDBgA1lF9RsUOrV3Ug8qAoo E2DBgWoIkO6JoEEBh78QEGwoEBpAKQsSPKh+ECGR3YU8BuNlsCGBBwIPHhQ4UArAWwMSLhSwoGEC hLUbAEQAIBtRBOY7oirU8U6AlAdHgT9YXICA7AeIDyhgQEHAgAp+CRRIUIUBnkM6tG8opsNMBrl0 BGUFAxEgUJIBD1QQCGg+DDSIzwMBIKBAcFO8sg4O+vGXA4If2EYMZqxIUQFlGciSRhm61JFBFBsY MMtdkhigoBE01jiVABwoYIAUpfTo449ABinkkESa4oEBOjpR5JJMNgnkZhU8UcmUVFZp5ZVYZjnl BwKEAAA7 ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/nav_about_off.gif R0lGODlhWQAXAMQAAP7+/HZ0Z9fV0mhlVevq6JGOhq6upcLBvKWjnGdlWIaEefb19GdjV6+tqI+N g9jWz+Hg3c3Mx/X1+WllXGtlWbm3seLe25GPhJqYkqkBAWhkWWlmV2hkWGllWv///2llWSH5BAAA AAAALAAAAABZABcAAAX/IOB54mieaKqubOu+YwlkXZJ0H/d1PJ7/uo9wSCwaj8VgTolsIiejDmX6 6w112CVny+16nUYlV+stm7maHcXDozRxlASF0UnzBjs8441TdjY7HAMTQn8cdH91HxMbex8aHB1b A25gHhtSb5gMGnOAO49pGpKjPKM6ikE8kYORfxscaXQcGxsDGniNtTh1aZaYFD5HHXQMA4AMGxp2 kcFWQH2SPrQDPJgfgD6YeMuPH9WjixqfhcJDHkLBSJEbFLUbE7gTE3iFrkKRW7yoQse2uN6qYdsh qRarb3Xy/SlnTgibD+qG0aph6A+CCo9wJFAyihCPK3X+aKAHUVKkkTeU/0mKNwBPgAsK6Cn79IwI OikNidBD4AGBkAQbGjyAhQ0OPog5OhAKJGVAgAq2PEm6AEBArQkNBBDaoEAACQARElAl8rHIzUpP JkAQAIFLAqEfUuYINm9gRkmF4BUAcGPKsg0XPCxwsOHtg5YBJERQkCCAAsDoLLV5M8CBhAAACgjq IPSA4AbHPmCA4IGAAXYPFOTomqACaQEVJgRrt7cBAVoGBCg9AGFcsmN7wXxgkwlfkEh7DlSgcOAA hQkcDABowKHAAgxcp1O4sAABIAAX6hTwwEBBAw8FGHeoxoFqAgIIDMPq7veVg8hOHqIlMimAhwAb 3BcANgYQABRzB3BQwf8DclBgAATJeOBAJA4AEE9ge1xTy14bILBAALl1Ah5ChSUwnnD6+ZLEBwUW cEEBEpxGQVbfaJAbBQ8Y8AcFe+HgwQXu3KcDVRMkc0WFOuSYFSbw4cKAR8FJVhJ/OsBDwFoCCGDB At8UmAAlB0TwQXM3MIAAAW5I+AcGAHzAwF7HVMPDBHtpYOICBzxAB2/YvMNjm1JGxESHC9ACS2Le SVfABgF0d6cCTlmg4wcEQJWAVyONF0BZ34znDgMReKAbBY0u1lgBAwSGYjrrPBDbEgPkyZkFay0Q wSfSCaBYAHiwaQEBBwBAywe/HrBeLQPsRUEnmA3lTlcARKvVWJbMRc6PEukUtAgFrFwDEyWYdBBA AQFMIIk7ATgQQDIMJCNWAO5gMoocgCDTxiAvLRrRL50AIsi116bBgTrLPgLMMW240QO3nRA0Ti1x iDSOX3FZ8xwH0CmjMIp7LCXcxyCHLLJwHFwSy7Ujp6zyykRMcck3KA/Rw8w012zzzTjnrDPOaqxh gw0sBy00yCNRMIAHIQAAOw== ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: image/jpeg Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/fact-sheet-text.jpg /9j/4AAQSkZJRgABAgAAZABkAAD/7AARRHVja3kAAQAEAAAAPAAA/+4ADkFkb2JlAGTAAAAAAf/b AIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoKDBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxsc Hx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8f Hx8fHx8fHx8fHx8fHx8fHx8f/8AAEQgAPAJMAwERAAIRAQMRAf/EAJsAAQACAwEBAAAAAAAAAAAA AAABBAIDBQYHAQEBAQEBAQAAAAAAAAAAAAAAAQIDBAUQAAEEAQMCBAIIBAQEBwAAAAIAAQMEESES BRMGMUFRFGEi8HGBoTJCFQexUoIjkcFyFtHxYkPhkqKDJDQ1EQEAAQQBAwMCBQQDAAAAAAAAAREh AhIDMVETQWEigQRxkaGxMmJyIzPRQoL/2gAMAwEAAhEDEQA/APavcMPPLL6ePHFHz8pmrKPko3fV 8Or48U3lZC1GbY+9TWF8khiz6pSOy7SrnFlIwgnKXK5fkOP4+Pdbk27vwxizkZY9BHVWdISIylwa /ccF+d46fH25xb8UgALi31vnH8EjLAnHJbmgJsboyid9dpth/q00W41c5jJRnreLPqukRj2c5nLu pHWfPgukRj2ZrPdh7V01x7M1nue1L0dNcexWe57UvR01x7FZ7ntS9HTXHsVnue1L0dNcexWe57Uv R01x7FZ7ntS9HTXHsVnue1L0dNcexWe57UvR01x7FZ7ntS9HTXHsVnue2L0TWOy1nun2z+iax2Kz 3T7Z/RTWOxWe6Wrv6JrHY2nuzau/orrHZaz3bBgdSkdis92+OF/RZ1jstZ7rUUT+izSOzUTPdcij WZxjs1tktxAszEdmoyyWQBZ1xXbJvEVNcWtsmxmTSF2lkzJpBtLJmU1xNpSzJribSzU1xXaRNcTa RNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaR NcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRNcTaRN cTaRNcTaRNcTaRNcTaRIwhd5noZ/5/cuVPk1WdPq40xr04RZyzm6lMbt6/X9NFWZag5GWItHyPot sS61DmopMMT/AA1WZxaxyWuS5GGpUed/nMtIo2f8TrjnnrDthjtLidu9ol3Dflv8zIQUInb3Jj+I 38Whj+mjLwzlOUvXERjD0HtIajtBWAQgjd2jYG2tj1wvdhjZ5c8rqXLcdFyFOSs7vGRaxSDo4E2r O2FqYZiXm6jySNJBYw9uqfSsY0zpkS/qHVa4c61Y5+PpMOlX7Zv2oKdiNo2ivWmpRE7vpKWMb9NG f/J108tKw5Tx1VafEFb4ePmYzjbj5ZI4wMnLLtJsYSwzZ25lBnf1JvVWOb0PDLO3w0FYjEr1aQo6 cnIydNpn21ooXnc3d4hbJAL4bx+Ckcvr70TxEvBjF7iMrVf3tSuFu3RZzeWKE2Yhc32dJi2Fv2b9 23V2wk81/wBGvEz5Ptu3xnW928YtDHBK5s7uxNYkGINr48d5bX+OVY5WZ4mf+1b3vuPpP02n5IBk gHc+BY8YY9PldhMSdvR29VPNC+JzeOplyPtmpN1vebPbYy2/qM2x2yw+OV0yzpDMYVlvh46ra5KH juPuQX7ExvFugGZ4hITYH/vHGEZNuL8QETaProseW1V8d6LEfbVuX9SeN4zbi8vYw76sJOzkDu2r Ybd/p1ZWeWIj8Vjir9GqTh467WJLtuCpBVOGGWaXqOzzWImnjhAIozkM3jLdgBfCnl9DxtEtSrFU gsFZF3tPI1WEYrJSGMRsBFhosAOX/O7K+Tr7J41vle3y45xE7EE2+aes/Sc9JqzsMwPvEHyLk2rM 7fFTDmrK5cdEt23aKK2YFGb0Yq89gGd9zDZjaYMNjXbG+4seDM7+SnmpMrHFVjY4P2tO7ctWIooK Mo1pCxNI5TnH1WjAYozfOxvNmZPNeITxWbH4GPfx8Y3a5zcpL0KcItPuIt4Rllni+VgKQdz7lryd fYnj6K8dKjJxlbkQ5CucVooxrxsM7mRyA0gizNEw/hfL64ZZ8i+NsLjYopJxmswxDXunx0kpb9r2 I2ncmbYJFhvZya7fJPKeNZscZVqTXo5r8DNxvT96YjYNgKaUIYwbbE5EZnKLMws/ipPIRg0wCEg7 o8kD5ZicTjd2Z/HbIIG32itVslLrccSzVpZjBZlW8QUVtFllWbMipwglmUEoMkUQEBAQEBAQEBAQ EBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBWIIPj9/wBHXOvydf8Ap9XGqtBJegjsFtgOQRkJvR3X X0cZpV9Mods8eFc6c0YWahvuEDFncfqdl5MuWYl6IwijzHcf7Y4Ep+KN3xr0D8fsd124/uHLPifN L8VyjYKOYCilB9WfLfWvZGcS804S7EXH8hZCs0mXlMRYWfVhcny38dV8vn5K5TD6XBhTGJe3jaGl QCjBr0hyZeru3zF/UuvFxxF3Pl5KzRzJXdy1fVeiHnlpfPirRKuEYRF3FeAfxvXjkNvDO09rfcS8 uE6Zz2l6Mo2wdOhyluheoyhCM9amM5SQFKQNLIckEsXgBbemddn3a/UvZnx1h5cJo5NL9XrcDW4h wr+1pcT7GKLAO8lwvnKcrBQvMADLHAQiD4fZ8zPpi6RWrW/7N18rthuVcIYxO5xD8TXZ5CbDlVOv 1SdgfRikztZnTWKU/qqlf2bOWsT2Q5EKlII7nMwe0uXynfaIHCNaWSOBo/xlCG0W6mM5L4JOFZ/V dm3keR5G9BerywRvDcvVbEOZS3QwV/bvKIl0/GV6rfLjDP5+t1jqmzODmeXbk6/JWoYJp4eRkuRx B04BirELiMAlFAJSu4xVxc5Ml8i5+Kn1XdR7eafiCoFBXaD9OGFoRKf3Lm8LM3zu0NbDPt/lXXKK xRjG0sq00vGBJHwfHBT6NWSChPPZawMZmLRRn0irMLtEBFobvl8Z0y6zONevRa/msFyPLxlKVYQC aX9Nc7e4Yyc6MjOZdKGEIhYoYowYBwPj5aKeOzWzGzZezLfks8cBxzXgu0asNh4ek8NRqgt1Chkb WPOR2aaa+tjGkxKTk0W7XIWePqVOlPBFD1HKCHlJooSc5WMerDHADT7RZvxYb4YTWJmZNm7lrvJc tcCzeCM5IrV068jyOZQ1bRsYQD8g5w4Nrn1bXRa48Ix/JMsqj2+RG/JZhjjBjnoGLubnmKnSeqbE Dhh+q5P8rvjHqsRhE1+rUZUZ/q3I1y5izWoiVrkzmaCF7hjWCM4xhieYei5SvHjfjLa+D51SeO8e zO9kU7FmC/wU8kYyBwoyEZbnEpZJJoZcbduAb+z45fx8NF01ik+5M9HP42naqcLw3HEwbuOcTmmY ndnIK/R+VnHVs65d2+pZpH6UK/utclvt2Wjr0hq1j5Kbl7Ux2HlOSaYLA9MI2ij2CxXJC1J38GUj GI/Ki1/dZK7yG7m5ohkgl5ewEglUuyVJY4wliN2ayEJkzmMLiTCPg+M+amWETQiWurXMYmExIT1d xOY7Jfiz800jCZvjxJ2W7USl1oI2WFo3ACzKtosoM2ZRWTMglkBQEGSKICAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgICAgICAhJ9nw8/TKWqlJrR5iWR/tXXHozlNJfTex+4h5Hjxryl/8uuzA efEhbwJePm4qXejizq9a5M7bmXmd6vMd1drcVzELlYBgmDVpWxnDeT/Bd/LOMMeOJed5g63CUJuT mdhhjwEb/wDUb7Bx9mV5+GNuR25Pjgq8ZYezxsVh/wAVhuq/9erN9jaL6OtJeHG7VZ08XwtwzKq0 wuW1i+Z/L61rKLJCqHFSh3hzc00ZbKlOvCRM7OIyymxi2Wy2do+C8UZV5YiXqmKYve9sdtdvWuCm 5HkYnLonI8kjEbYCMWJ/lB/LVb5+XLHOkMYYRRzh5n9oCBiBrpCTM4k1Lk3Z2fzbEPgkTyVZynF5 TjnOfj601iN4Z5oYzmiw47DIWchwXzNh3xqvVMUm8uFJno39GLD+nnolY9JKT2Q8USRlPSYSEdGJ Msoj1WImPRb4riX5G/DSiJhOZ3ZiLOGwzu/hr4MpnlGONWscZmWXPcVBxPNHxTSPLLDBDNJLt2jm YjZtrZd/l6anFyRONZ7rnhMSysfpXC0aE9mgfK8lyjSHSoNL7eIIYXYTlmlZjIWybbWEXz/DETln M0tEETERfqq3eRCxXEA4OtSsPIG+eG3NKLR/n/tyRx648Hyt44TXrZnLKF60IxdkOYMzGXK14zNm Z32ELZbPopM/5KdoaiPhX3czpR/T/wAVvernEep0okrQ6nSiSM4WIlHTjVrKUS0QeqzKzVLRx+H0 bCspdb5ShFx9+Kk5vJMdOC8RbdosNg5REWfL5cei+fBYxzrj/wCm8sKZR+DQMceGZa9EbGAFBmwi pKsmZkVk2FBKgIMsIogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgKhhvFc/Ur NXI5/jRql1InbaXiK78c1iHPlhzON5mxxl0LNd8GL6t/M3mzrpyYxlFGMM9X1zt7umlytRjA2Y8Y MHfUX/zXzuTgnF7sOWJhu5iw7U58fyPhc84s6Yy+X/uhPNY7JmeJtzBYgJ28W8SHy8dSXLgtyQ6c t8XUos1HiK4TPhoIQF3fz2izL6fWXg6Q8fzHdQHMTRu+xtNF6cOJ5c+ZhxnO1gZ7Mz4ihZzPd6Nr hXmwpDXFyVeu7RPibHaYXYBJuR5OYrHJGRPq+4iAf6RIWXyuKNs5ntL6PJNMIfQ+1KsM/adys8jR xzvNGcnkLHGwu/2ZTnzneJhOP+LzsvbHbFDiyJuehm9pA77WKLJ9MPDG/wAXwu8cuczfH9HPLHGj l8N3EdCn1+P4uPkr9x4vbDOTAMQuBkRuQjKb67W2i2vqt8vHWYvRjCez2XbfJcxzRS0+4uMgYHj3 RyxxSgGjs23Eu710Ji+xebliMf4y74zXrDzHbvBQch3Ja46bWLj55gnZn1cIZNoZdn/OLi7/AFr0 8vLMccd3LHjicnS539wJOM5qfguA4yuUPH7AvWZyeOPqEDH0oxjEtziBC5E76ZwuXHw7XymVz5Yi yv2V3DyJc17aepWJ+Ru2LBzbycoYyBunHF/bHdjbrnCvPxfG8ycOc1T+43ct4eR5DgKdKq0slKN3 5GU3GUOs8gs4s0ZZ2bM/i80+24rV9zm5JrSYc+G5wd6nWp8s5QT02MKXIgzmwRyuLlHKLa7XIW1b w+DZXTKMomZx6dmMdZxv1VuU4SfjxjlMgmpzawW4SY4jbxyxN9S1hyVt6s5cdFmS1Rp9hWrc0A25 YOQhelUN9sclo2GOFpMa7BI95N6MsZRM8kU7NxMRh9WfbF7kuQvR8bzVqO/Xubo+kNaCEYXcXcXr 9MWMcO35iLROTDWNoZxmJnVQ4MKBR3eQ5P8A+nw8M9i+Aa7vau4nGOH/ADGOG1z5eK1yZfGPdccY rPsjiu5edmlCflHrhQmdnLg468XQhjL8vU2dZ5GH825mz4DhZzwxj1uRlMr8XB15O7bHDEe2CGXc Umcf2Hjadny//QW139dU8k61TxxMuZR7u5e7I16mUNDgjfdS4pq0RtLAztsO1JIJSOUg64Bxxnxd WOP41mb/AIrWei9y5jx3LuVAY4huVY7dVpY2mABm3MQ7TwzuBB/g7K8UbYzWSawz7z5PlpeUDjoZ q8DS8LTOWw1WI5nKwdkCcCL8LDsyA+DO7rH2+Fpn+o5MqzH4OW2x/tXeZc6Mm2qSrNtqyMm2qKlQ EEoJRRAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBASA+mVKXR5i1yEtuX5ndyf RvRejCKQ45TWV+LtCezV6sZ4kLUBdtPuWfJSWvHZ5yflrnbl9x6nTsxPrEDsWW+xXLLGYTHDKJej qd88t3NQKjUKKiTYC5NLkz6ZZzsZm2t9v3LyTjEy9W0xCK4VHaxxjM0kTsA2IdriEmCbJDl9HHx0 XDK2TrGU5Q5/eXLSFK9CsfyRNmV/B3d/JfV4uOmNXzubkmtHkWgd8vhd4yefS1XE5Gee3ei4imzy vOQgcY/nfOg/Bnxq/ouH3mdMaR1d/tOOdqz0fY+Lo/pvGQUgfLRN87tpk31Ml4+LDXF7M861h9A7 dYm7B5TOj9O07P8A+yuXJ/tx+n7t8duOXzLj+JqPx9UnpxvmIHz0x1+Vn9F7cs52s80w+j8PHd43 sO1yHBVBs84Ym0UZNn5mPYLYbDuID821vFePlnbk+XR6sYsz7DHvia9LY57kp56jRuI15K9eCN5H JvmBgiGX5WZ/E3/4Z5tI6HFXa7ndoWwr/uDzwSfKNm3PHGT6NvZwJv8AHa/2rpzX44+jHFXySody doczX7g5GzWqyWa1+f3MZxC54cwFiEtraYMXx8MLeH3ETERPoznxXmWvtSGap3dUhsC8csUjjIJY yJFG7sz4/wBTLX3GUZYs8MTGSx39wnLF3Zb5KOtIdEqVfNgWdwF4Smc2N/Btouz/AFLP2vJERq19 xjM9HmSinFmcoyZibI5bGWz4t/gu9Yj83CMJo6rTTUuxeenss4Vi6XsAfTfdKRmjaPPqW1ix5Ljn /sijtj0mvZrvAf8AsLGHz+sV8f8AlXSJ/wAs/wBrGP8Ar+rd2iMjdyce7i7N1W/g6zzZVwocUfOr Ps877/7kqcebRclb/Uh4+QmB29wFmVwZ2kYgfX1Z/isctscfo3h/LJz/ANa728C524JeYlV48SZ/ iL1Msta4s3dPsybkB7t93ydya1bvB0DszhCG3AO0TMMUcQeOmoqcsRGNIawm93N/U/3Ar4guc3Zi tw/JODVePYWMdC25q/hy3yv5smOOMwk1qrWP1i1dG7yd6e9MEXRjeUK8TDHu3aNBFF5+q6Y4xjFo ZmZdPuyOV+5a5sLuD8HxwsWPld2ltO7ZZvLLLPDNMMv75a5o6U7KDAefB10/4YlmIl6KFGxmL0UV lh/RRWTZUEqCUEoogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIos+rG13h45 Y45BkkNo4wfJGXljyXr2jVwiJ2WOU765G1B7Di39rXYXE530mkz6fyN9Wv1LyZXl7Iizy70iKRhF iklkfTGrk5enm7upt7JOL2vB/tbyY8ZJNPaapcs7XavhyFgbw3/HPotYcuNehlxTMdWHs+a4KwJ8 jXlkCJ8BZgEpxw/iJsGSxjzws8mEZTWGuLLKLKDcfTtTy2ivx+3InPrZ3P8ANrqzas7fFejj56RS XDPhymavK8rywyX24zhIzvTyvsiaAepKfx2NnaPxJ2TP7mIi3VMft8pmvo972F+158ORcpym0+Ym Z2Ac7mgB9HEfUn/M68sTM3l65iI6PaewiDXG74uum3oxSKotS8uVMqVXk7FKrIJjNFAFYmNpBwWX nhldtP5SZSIxrWfQvSYhWhrjBBHCDu4RCIC7vrgWw2fBb3vWGYiyxX5HlKbP7G2dZ3fJYYTF/DRw NiHy8fxfFYnCMprK7KRWu4pOQHkrXNWJbsQmFQgGEIoGlbaRBDsICLGm6TctaYUpRKzE1q0RQ2Bl nmsWpbdmzL157ErRiTk4iOcQhGDYYG/KtVilKQzSYmtXQfuTu6ONwrcuYi7YZpoopnFtW0J2Y3/q d1z8WMzeG/I5UI3Bs2Ldm0dm7am9xNOQxxvuYBjHaMQxiOGjb4+a3WKUpZi6zy/L90cnxtji5eWM aNuI69gOjCUpRSi4GDSOOmRLxds/FZjhxiYy92vJMtg853DDCMNW+wVwbEcEkEMsY65d23Bvz/Ut ZccTdneXNtRchyNqG3zPITcjJWfNaI2CKCIn/MEUQgG7GmS3P8VccYhJltsvZsVoaj2TCnFO1oq4 tHtOQWwLkRCRszegkysTG1fY9KN9eezWmGevI8U4Z6cjMLuJO2M4NnFSkTY6XaKMUlQG2zySS7zl KwWBkc5DKQj/ALYgLPuLPyik0mywvTcz3Qb5j5TYbPpKVatJKzeTCZR/e7OszhC1VK8M0bEU1mW3 PLIUstmZ2cyMy3E/yiAM3ozNp5LdqMxN1yXme5CFhi5LG3GwpoIJyBmfwEzBy+0nJYjCGplSjjuv PNZu3Jr1ucmOSabpj+AWFhEIhAAFseDCtxSGZWbfI87LTGnDf6MIg8QO8MMpxxk2H6ZmDkP3/Bc9 KS1E1hpEXEWF3d3ZmbL+L49V0qzF4T5qVWE6qVGWFAQonCBhBCAgICAgICAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgICAgIRc+mNUoxWNqPlVv3XXb3Ph+XH4cfBZjajr8at8PQwO3G9YmrrFH uv29/QOs/V//AGNen1sYxn/teW7/AFLPyWz3h9f4Y88ZWVswDZn5vtSNvRYomT9I3F1/b9THzdXp 5x8dyzNWmun+nbT/AE3223/ue16f/q6avr7s3D365W/kxZoPPmtXSysecv8Af9SXIai3LUV9GbNR 7vp6JNUs1vuSKlmt8/er8izB8q/Jn4sXz9PqV+S2Y6/FS9EsjXPxSK0LI+b6ZV+RND5vplS5Zk25 W5Zk2VIqWZNn7/vSdiydUuWT9HU+S2Rr9/8AyT5FkfN8MK/JIoap8iKCnyWyWS5ZOqXLJS5Zklyy NUuWHS62QlyyUuWEuWEuWEuWEuWEuWQl0sJcslLrYS5YS5YS5YS5YS5ZCXSwlywlywlyyUuthLlh LlhLlkJdLCXLJS62EuWEuWEuWEuWEuWEuWEuWEuWEuWQl0sJcsJGy46+59PsT5PP8dvV/9k= ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: image/jpeg Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/fact-sheet-collage.jpg /9j/4AAQSkZJRgABAgAAZABkAAD/7AARRHVja3kAAQAEAAAAMgAA/+4ADkFkb2JlAGTAAAAAAf/b AIQACAYGBgYGCAYGCAwIBwgMDgoICAoOEA0NDg0NEBEMDg0NDgwRDxITFBMSDxgYGhoYGCMiIiIj JycnJycnJycnJwEJCAgJCgkLCQkLDgsNCw4RDg4ODhETDQ0ODQ0TGBEPDw8PERgWFxQUFBcWGhoY GBoaISEgISEnJycnJycnJycn/8AAEQgAPACjAwEiAAIRAQMRAf/EAJwAAAIDAQEBAQAAAAAAAAAA AAUGAwQHAAIIAQEAAgMBAQEAAAAAAAAAAAAABAUBAgMABgcQAAIBAgQDBgMEBwcFAAAAAAECAxEE ACESBTETBkFRYSIyFHFCFYGRIzOhwVJygkMHseHxYsIkFtJjgzQ1EQABBAEDAwMDBAMAAAAAAAAB ABECAyExEgRBURNhgSJxkaHBMkKiIxQF/9oADAMBAAIRAxEAPwBCW6ZsqlamgUmlc+zErPIxXSxK 5dpyoM/04HTkm3ikjGqNnCa6j1UriaOSsjMMiPmr9vA4EsgSSYk9QvQUW14iQDgJm2JXuJDViQrU 4nsxoWzya09vIfMvpr2jAHpXaJG2O03HSNDvLrYcQVOVfjg+LWRBHNBk+rUp7wceS/6d5lbOvcR2 L9kTLxzBDD7IsbUUqO3EbWxHZi6jMVGpc+0dxx6J71wnHJmC2+WMalDMNNoQqSE4iTbV3GVLSX8h jqnBFaouZX+LhglLpPZTFKT36yRNYAA8xfcMxACwA1kbxy7sGcG+UuVUDKTbn1PRdKI2lgPsg289 E7BBERbWhWoJJLNQA92eMa6r2obNeKLWWXky5rqYkDwrjW57Dq6e5lulu4hYyvq5sjNRUr6QtaYW erttS+26S2iImulIMbDKrA5/AUx6ajlSq5UDKRNdusdW9VSzjiyiUAAZD9pAy6j6SRpembYnzVWX M5n8x8VrXppb9JrsPywhOoEV4YSJd33LZoztcV26mGoKx+jzeY0PxOHDp/ert7ARW2mZZFBlYnPU eIOG1kiJRmC4J/C85ZCcDISwQWXJtAfULWRJWUE6SKVxUgilulIkhMPLajEjI0Pfg1AlxXUbYAn5 gTia7lmsSlvLahomFTTxxaywTaNIL/ydVoqttkYx+RUctjbiYxQebyroC8Cx7MLF7uu0bTu0kd7b rftFVGgVgFVxxDPnwOG/fNv3zbek7vqH6ebSAIvt56guOYyxh9INV9WVcZ9050fJviC4uJzEjny6 RqY+NTioltBNhYAsto8aZmYSDlRXnUkNxdNNa7ZHaxkUEaSFgD36qfqxbtd2tNza1tUi5VzzFAUm obP5Ww9Wn9GbSTTJLfy6PmGlQT4Vyx56m/pRt1ntz3OzySxXkCmRS7ag+nzUrTI9xGON1RZicrc8 GxiWZvVHtARQDn5R9mWKfUdxFdWO228Y/FhDiTxqcsANt6k3OXZLO7njR5JBy3c5FijGPUR3mmeC m68yK3tbmalJBRQvZ247czh0vkWEg+iFe2On7P06sdizzFpw+TV+nHYu/r0VnP8AV1Ul6Rj1KUV7 SYGoSlFJ8Ub4dmAm67VebX5JRqEtSkiGq1UgEd44436G3SVNLqHXuYAjCt19sdoNk99FFpazlilf RUDl6tD+X4NXGtsXBIGjlbcO+cJRBLhw7/VXNpsrjbemRG2pUEA8rVXzsBn95wxbXbxymO21g8pV WlfD+7AlLqS8sFty5kDyRCuX5YKkk/dgzsMEgvpJNI0hgVJ4EAf34+dXDyWtN/lY5f1K9HYWqnJw D0ZG22pQtcLm7b1tO2BoiTJcCQQkZhUckDzH+IHLDlcS64Ty8zXiD3YzjetvEu9OojEisAJCRWkb DSxp3+bDS3hcKiwmuAnFgNxzrnCE4cjYZeUn4h2CtxbjDerzLaORlyOsjShDCo0sx83jTFa+uZRa XMPLlWSSNtDRMQD/AOQcPgRi4saRxrHCoSNBREXIADsx41rqADAt2AGvDwwqqmI3CyuksDhn07ox wG/VLY3d5tsWzWN4glSXkYMzsTUtUYCzKCrKqlpmGlFXM1PaP14a9z2a4eH3VZFQGh1KABXhpypg M1pDaRlz5AfUxNWYk8Ce3PHoqOJZc1xcROgOJMqz5kIEiAzqsR6qjmh327juNIkUpUJ6QCiso+ND ni10hua2N+YZWKxzig7tQwS6z6a3duo76SG3aVCsMh0mpGqJOP34j2XpjeNvuLLc7yyb20smn06i o72GH+PEB2iPukF8xOU5SLmRJ9ytBs4N1ulNzCoFmtBXtPww1/TJJYFeS2JbT66Z0wkN1om2PJt8 cLqiuBTQace+mNktN6M23QvyACyLWlO0YDkZRyFBplWImRMdw6Fisy613Oe06RvtquXnaC7QQQxF qoroectAfSPw8J1lBu20wQpaNcIqooRoI42A/aaR5Tln2DGq9b7Fdb107dwWmlrhSs8USEBmZDXS Pjhe2bdIY9rMlyukqNGlhwbTwPw7cTvwHAOcojiwiQXk0u6IdJbxum47ZemaSR7iyNUZkUM/ZkoN MVbGfqXe9SXvuo4pGZWW5hiETRDysqvEQ6vT04l6SvbqNrsOsLLMy6ZddG8ubFl8flw6m6jSzlmy ZhXMcDlXPxxzkAuAHyEwMAYgmRwGXzvOt9sFjFHK3MiZn5cR4LR2xEu/XckBaQ1MbVVGPlAOCfVN ybkR24KuFIKheNSNTV+0nCy+yX12kklt6VbSyk07MbRnGYzhkjshAyPQPhF/+WT6fTH6NP26sdhY +n3WilOzRx7ddaY7GzR7jRTtj+F9a2UYyYJn8cTbltyblYXVjIBpuIniP8alceLFqUwSJVVqxoO/ BTZ0fuhok6hIXRG2vu+z2kM8rQR2buNxZDpbXAxjaKvZqK/dh92vcrHdHa3gtZIY49SxT6dKsEOn ytWv34XOlkSHqPqTZokRkuJYd0hqSKpOvLlC9+mVP04b7e2mtAumLyxjJRTPwwqPEhGcnhEh3yHf sE0N5nGJc6DroV69hHa25CzSsFJYa2BOefGgyzwl7oK3F3KxZSoUpJG1CGrQZ+PDDvcNM1swkUI2 RNDUd9PswvtttrcmWK5ZilyoEhDaCQrBl0EcM8B8vgeUCFERWNSdMojjXCAkZlyUDs7db2RIY1Ms hHnMjMwXLMtqJAwy2tlt1jOiwW8fuKFhOyLrBrpOlqZDEU19te0QC3hCxIgpoXifjXOvxwl7j1Lc NucEluRyQxWcE58tuJFD6sW4nDo4YM7ZCUzjcf4v0AU22zuJEQYx1ZP25Ri7sXQk/i+Zf1YVItjW a4VXGqWtEqMo/wBp/iBhrMjyQpoyZlBSvBRStcVUVYA3L8zOdCntNTx+04akAsWGNChQSEm7wbSL driPlKfyxUjsEagfcMXNvv7VdMLqtDkARUYA9XSi36gvIwc4zEv28pMURcB0BrnTj2g4oQl8pNI/ VOm9bVt24WEkRhjSWQUWQKK1GeAiHcYGPtOdKqKFWDRRSQKeruwOj3C7uLm1iZyygaV7yWy+/DPb 7D169yUWS0sbEUo8ztJKF8UjWlf4sYWVzxsYlX3GxtxJEdFZFlvMQs5Xs4xA41XLs2a5Vxlkd/Et 3dxhR7OSeSOSI55K5HA43D6ZcQWzRT3D3LhRqZvKKt3JwGMc3HYBzGu4kpbXUjxz0r+HdRkq/wAN VPvx0apGMjIZAdh2W9R22RbBIw6ZtgsNoijDh0ET18hVezswUn5N4rbZZ0VLnVCixeWrsjGikcDQ ZHCtsO1MPJMQdGXmrUfEYYLLctvh360skmjjjsvxJXdlQNcOrCGIE5aiAxoMdCO6UYgkuj7bZeE7 viwb3WP9R7HLYtHHtNtKJVqHJq2YOYYntwuLvO5wiRGUBlakiUoQfhj646g6K2rqNRMzy2N23mNx bFQSSP5iurK33V8cZH1F/QneLYzbjtl+N1dzqkgaMQTU/wAnmZH+8eGNo1yHxmBLOqWN3ysY+oXW mvb+Zw+bVTHYs/S92pp9nc19z7OnJf8ANrq5Pp/Mpnp9XhjsbbR2GisvpEdQWtrE00sixRIKtI5A A+FeOFDfP6qxeaDal1dhu5uA8UT/AKsZrvn1/mD6prpnyqflfwdmKm1+z0jn19xzBq18dNP5ery1 4erPBNhLHaOiF40YCT2zBL4DHb7rRult43CDeW36+a550qLFbxxyiKaVGPM0SK6SDSxUEDKnHhjW rLreyKL7hJlorMzlldaRisjVCrkD5a9pxkexcnlvx9zU1rq5ntK58vVnrpTX81OPZhhy1Dm6eVzo +dorp9vT/a6P+3qpq8cKz/sP8fynMvAw3fhMu49bRy30kUMqxxRKGeC6LRsrFeZQtGGWmnAndutr G2uLWGJg8U0bLcXNr+OISGFPJqVqt/ZhM3Xn/h83Tr5lx7n1fmahWtezTgM2rzcO3hXER3uX1UgV dyyZb273nenaOxuFbnERwSRD8QtqFCxfgSMqEZYtWuw7rtslr9ZlgYtIpkhjZmuCgYGQ6FUgkLma HCpt3uvcn2uquXP01po/zac609NM68Maf0d9Vrf/AFOvN5i+29x/7PI0jTzaf49+A7YkD/JISG4N uDF+yJGzaG7FNsl7E/liIo3aMsuzjixZIjzq7ajoBK0U6a8PV3+GJbf6Xyxr5XM/mczTqr46s8XP 5Y5dNHy6aUw2iTtDhilxZy2ixXrqTT1VuOngTFT7Io8DbEy3RSCJdczsERV4knHv+oP1b/lV/wC3 9tytUenVq5n5SeuvjX7MEP6acv3l573T9RovsNNdNP5tK5asVS+YjuLnqtC6X6ZstrEVzOqzbgMu c2YjY9kYPD48cOnLUUT5QNTnvp34BWerlvy6fljk/vU89PGtcGfP7PL18sfGlMWjt91tBmwol0zN Of3SPiRkP7MZd1h09dbfu889kpEU595Ea1Us9BcW8iny5mPmIT21GNEm+paJPpXK11/E5nrrpy0V 8lPjivvP/wAm2+oV93RderRXVlqry/LTVThjWltx64L/AEUWaDoen1WX3V8JhbR2kf8AuLsaYhFq oX9JyOeXbXhgltfRUM95YJP53LGZn4lrioEkv7sUdQnicWNo+k/Vbv2+mmhtGqlddfx+T82nl6df +OHPpynv7rn09xy15VPTysvR4V44mrxCczUQZF8dgr2+Uwh5QREN7lM4xzUIoc8fi1p5qV8MRy6q +XjioUlRe3g169C6uZzNVBXXo0a6/tacq92Ox4/F1dvH/TjsThQv/9k= ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/in-english-white.gif R0lGODlhQwAVAJEAAP///729vWNjZQAAACH5BAAAAAAALAAAAABDABUAAAKUjI+py+1vgJy02ouz 3mH7D4ZAJ5YmSJ7qSqWV4AnyLMKAfeGWS+mYX4tleBMbTGYB3m46pFGCo0GZux/02cthjdupF7ls WcPk6wwbjn69WbaEuHaXi3Ry11yfw9N5ORt916YmlvP3UhgHFghYscfYc/ZItQhm18hiomSyh/ki 1cnZKYoROmo6UXpqmqoqCvEKG/taAAA7 ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/tab-divider-white-left.gif R0lGODlhBQAVAJEAAP///729vebm4gAAACH5BAAAAAAALAAAAAAFABUAAAIXjA0JodusYJIuvmvz xFsHMQngJ5LlERQAOw== ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/en-espanol-gray.gif R0lGODlhTgAVAJEAAObm4r29vWNjZf///yH5BAAAAAAALAAAAABOABUAAAKujI+py+0PgZy02ouz 3jvwD4bi5Y3miUplynIC8IqrJdR2a74xtlNz1cMJaaRMUKI7wmqUG3LZZD6lSKry17xIg7tYt/qE TbzesPhcwY5t2zHQjYbHw1902aI2Z/VLZ1/e5VQ3WMSjJcf3Zmd2d0aIZ3TI9+h4R8aIOadixNZ4 5Pc31cPkuVaXNhSilAqQx6r46hM7GxIwQIurYXub2+szAOwrvAsMYXyMnHwAzFwAADs= ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/printer.gif R0lGODlhEQAMAMQAAP38+o6NkaassHOGpK28xUhNU3iEi2l2hoaWrwEDCOnp6LTCyJemvDA2PPf+ /sPGyBQiN+/w6yAtQ/b29wUUKNLKz9zW29TRzyEfJvr/98C6v+Lh5p6bnP7//f/+/////yH5BAAA AAAALAAAAAARAAwAAAWM4Cd6gBWcgXEApNN5sBcFVa1wBaB3LzxpGguwgrHoAJ3Jh6cIPDiBSyGB qSI7y44zoohEGgJN4pFAOgzoQxptoJATLsNiTp8TIIJEvnMODPwDBwODAxQIBRgOZwQEDI4ICIMI FBJwihgSDRISEJ2bEAlTfBkbCQyQkIEHFFMJHRkZDhMJtLW2Dh4fsCEAOw== ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/email-document.gif R0lGODlhEQAKAMQAANDQyL22vUxJTeno7Pz78k1LLfbz7PTzxOfmxPj21b3Fwrm6u7m6xuju8Nvk 1aimlz1OS7a3quDr5/Hu1KempZepqeHd0aazroicnaSgl+rs4sC5wOTw2kFAIkhCQP//+CH5BAAA AAAALAAAAAARAAoAAAVxIPEZguCZpaeeg/F9U9ElyWEfnARBQPNkiULwhjg4IAqkhECITWIIxARR UCgEC8nj4ZwWZFUAxcNoiEgWQBoAsF4qSkrGUFgvIvg3BlJ+GU4oJYIlDBIvAwALCwyMjBsBjD0v HxqVGg4NEhIDAw2dBCEAOw== ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/pdf.gif R0lGODlhEQANAMQAAGRnYKampfOZocjExP/Jx+oGG9XOxvX65eHc4JRVVfv99MxrcvT9/v/6/ooy Nb/Uyfz1+//5+f/9/v/++u7//P7084GLg/P29Pr++fT89jUjDk5NT3OFgP/p7v7d3/r//iH5BAAA AAAALAAAAAARAA0AAAWeIBVVgWWW3CBJ14Rhh1DMdKFtBiQ1URPXNM0gMID0RgKHculIADYbRGPa 8XgWhOxC0OkwAIMpD3LhPCgT7OVAAVNWve8jA3EIDmxO4LJiTAEIHQQCWAQKYB8ZHww9AAYeCQJJ CQFgCi8NFG0eAgkeCggBATgVChOZFBwJDoYTRh0JAxETlwqHDwcRDBcMEBWOFbMYEwcAxlDIG0IR syEAOw== ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/red_go_button.gif R0lGODlhFwAPAKIAAOmMis8EAP/+/txIRdcuK+NqaPXMy9IUECH5BAAAAAAALAAAAAAXAA8AAANR KLHc/urJSasdYAxGQCEVYQhkBJRCQY3qsRWCcRwjKMUBoR2nDas3QGAkGIwOi4FAeJMFlJji4rSR nAzRAYFUgDknJ5IBZBTbLOi0en1jOwQJADs= ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/bullet_sm_css.gif R0lGODlhAwADAMQAAE9PTwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAA AAAALAAAAAADAAMAAAUFICCOYwgAOw== ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/backtotop_red.gif R0lGODlhDQAOAJEAAKkBAf77+////wAAACwAAAAADQAOAAACHJSPqcvtD+MJwVHQLsArbA9UCEiR YymUoqG2SAEAOw== ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/footer_hhs.gif R0lGODdhJwAfAPcAAHR0dOrq6qKiovX19ba2toODg6ysrI2NjcvLy2NjY9XV1cHBwZeXl+Dg4FlZ Wf///+QzBIbkMwAAAAAAAMj4EgAkQdR3ZMDZd8j4EgAAABUAqET5dyQAAABIDRUAAAAVAMgvFgCg +BIAmPkSAOj6EgDwiPp3cDj1d/////+oRPl3cH31dzqK9XcAAAAAAABAADiGSAC4+RIAAAAAAMtE +XdgiBkAzYv1d3gHFQA3kPV3iIgZAGiIGQCcnhkAHwAAABEAAAAEAAAAAwAAAAT7EgBAtHQAPPkS APgCFQCInhkAAQAAAAYAAAD4AhUAgJ4ZAHT5EgCqm/V3s5v1d3ieGQAkAAIAqJsZACz6EgAw+hIA AAAAAMtE+XeAnhkAzYv1d9gHFQA3kPV3nJ4ZAIieGQAAAAAAN5D1dwUAAAAoAAAAAAAAABCdGQAA AAAAAAABAAAAFQD8+BIAEAUVAOT5EgDwiPp3iBz1d/////83kPV3VpT2d3GU9nfgRfx3ZJT2d4iI GQBoiBkAnJ4ZAADg/X/M+RIAAwAAACj6EgDwiPp3IBb1d/////9klPZ3hJ32dwcAAAA4AAAAiJ4Z AAAAAAAQgRkAuEgBAAAAFQB0+RIAAAAAAHT6EgDwiPp3iBz1d/////83kPV3Ie/ndwAAFQAAAAAA Le/ndwB51HcAAEAAAQAAAHCcGQAA4P1/RgBPAAAAAAAAAAAAOAEAAIieGQBE+hIAAAAAALD/EgAJ SOl3mBDpd/////8t7+d3XFdDAIieGQAAedR3AABAACAAAACwiXS2GpzEAWWR7NIrnMQBsIl0thqc xAEAAAAAvQEAACQAAAAgAQAAZm9vdGVyX2RoaHMuAAAAAAAAAADILxYAAAAVANT4EgABAAAANPsS APCI+nd4HPV3/////zqK9XfUpud3AAAVAAgAFADlpud3AHnUdwAAAAAAAAAAAAAAAAAAAABE2kQA JDAWAOTtFwAoMBYAmIZIAP/////ILxYAntpEACQwFgBz0EQAyC8WACH5BAAAAAAALAAAAAAnAB8A QAj/AB8IHEgwwIICCwwkKMCAAQGCECNCDHCggcSLAxc4SLBAYwKLFwkUwFjQgQAEDggYcMBgAMmI Aw4AMIBxwAIADhwseAAAgMuXERUCAAn0AYICAggIeFmAZtEHDRI4MBDVZFUELwGMhNiAwQIFYEEC 4CiA5YMABAgQfarggAEBMwksQKDAAYAHBxkEeHpxQdkBawUGQHDS7V6+Cgoc+MkXKk6/Sy8qIHD4 aUy7FDE/xCiAwVMGDhR4bFD2I1DQlSGCBVvAQYOVDVo3fjAAQQDGYBEwwGmXgEucBhhUhMqAIWOM FGUGJkigp4PZQAE3aDCYYWroBAnfTMBAgIC3cF1frW9MOvj4iAIK3G28gEDL2Q0ILCx6UwH0qh0d HCDZAMHxoqV1tdFyBBkAgH1PBYATAw0s2OBWIUUGVFQJIKCRTh7tRFJxTyUAQAB2NXCAXf9d1FBR dakUWgEJNEZXiXjlJKNnIwbgIYwYGWBbdjICQNlAdd2F01gyJrAfRm1hJVFXUrGkkkKhzTZAcZ6R VFYBDGEn0ADNfYcgQTcNgNMBm2kp2GQEyDRAXfpp2FhAADs= ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/footer_nih.gif R0lGODlhLgAfANUAAExMTJGRkcbGxlFRUaysrLGxsb29vX19ffb29pqamqGhobS0tP7+/srKypaW lomJiZ2dnaWlpWlpafz8/PT09Pn5+V5eXoKCgo2NjdDQ0Ozs7Obm5uTk5GNjY8zMzIaGhurq6q6u rtra2sPDw7m5ucHBwdPT09jY2G1tbaioqMjIyHl5eeLi4t3d3VpaWtXV1XFxcVZWVqmpqXV1dfLy 8t/f3+jo6M7Ozre3t+/v7/Dw8P///wAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAuAB8AAAb/wJ1w SCwaj8ikcslsOocTDtQjMExoz6yQstkFGNvI45AxtFpapwp1i9h2DArmITsYDoECIp3MZEASEhcX BRUVKR4eLgR5CQ46fEUUIi8XCwccBQ0cYBU7FQIfCwF3DnuRW4IOFiFKLAkBAS0PCqd8NRABBzc1 tkkmKhgeAa18FA4NCysjRhsKIkYeJQQRGCx8IKbHRg0dAAkbYEQjMgUXGWkVGXMJAkQICQAuEQED tUQTEAYIFJ5ZGx9CPCBBRMQMACsKrADQYcCKE0MYQGiA4wG0LAIuNBBQQwiDAgO+RYgBIIYCCAAG LBDnjISCBVpIGFgwAx2IBwAkEPiQcwEK/wABJQAF8WlBiAARtLyIcGEfBRgAHhDwhkHDDg04O8jA AOAAggkFQhQooKXEBRjQDABwkGBAB3fjGkJwAKDEoQQYCKQBUeABiAgD1AJA4SCWYQdCAYQAoEDD AgMkYGbhsLPDhgIAUhxAIcGC588WJKD4EAFAAQ1kGpjQouFEghI2OLiIAYGA7du4CUCwEGND5AQH VmuR0QGDAQYNLKQcwLy5c3nuSsxQkABdlgoNTkwYgoCKgO/gw3vAIqS1AHF8PCiQ4gQse1Q7DAQY EcCXkgkqJEBExUDBtbkXJZHDXAEskIBVkSCXQAQwrDAfA+hxZwIKBagwwwYI+INKC2aRYlBDAyJM cIIJL3AwwgIpvPAABS0YAB8RIGRAwzWkNAADBCoIIAF1OyiQ1ItIIHCAAgdgYAcJBxzwQQAQXAPk ERqQlUAKAZjwkgCabPfklksEAQA7 ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.cancer.gov/images/footer_usagov.gif R0lGODlhWwAfAMQAAP////Pz87y8vMPDwwAAAIODg6Ojo9TU1Ht7e5OTk2tra1RUVFtbW/7+/pub mygoKO3t7YuLi8zMzHR0dKysrLOzs2RkZNvb2zg4OBkZGfn5+UpKSubm5kNDQwsLC+Hh4SH5BAAA AAAALAAAAABbAB8AAAX/ICCOZGmeaKqubOu+cCzPZ9OU9lgd4k3/QJXNR/pcBoyKRBNsOlEfgaNS WTAWk4GG+OzKNJLIApPBdAoQxTlA4nrf7RGEYnlkOhPKhQ1IJCIJJjkANls3Q3BNEgpmWUwlRiIf IgEcHERDOYeJQBUMZwcCBgUTCAkCIwcJCggHGgUWfhMGHxSEOQEKbG6cLQcIEwI+ARIExgJ8DRoH GAUBY5MAHxYeG7c3AgQVhEIpg00NAgkSJhAexhcmEQcUBKgkHR0AWyIWBBbemILfQR/kI0Q4nCPA A2CfCwoIBCIhQF4OCBkIZODQC4YPXgKNFeTW50BCDxYqfNhlgAiFiAQc/6w4QpEDHzAC0gHgAGGE Bg6PUvBhkZGgugsGjBnz8CBJD0IFIhjDwEuEBgcLLCgQoGDbhQkMLDCIEKBAgREOdK1oeqLnxhHr AnQQyhZBjgPOUA5AMWADBQgHJiyooGGChQsQBCxwQIEBRQ0KFjoxa2IcAAgFMAwU+i7B3IQEJqAo oOCRgA0DJGz4B8AAAwGnARxYMPcJYy4RJGgBEOCAAQUoEcxjQEFAAWMZan5D/FUEh9OmKYoQPQDB V9M7m5gzRjrHumCQMNwDMMCCg+8Zzhm4NSJXBDkWRFkQDkAC6woWOEw4T/aLdm3XCE2AYGFBDx8J EHBeAaQhYMwGPnAwAP8EDUwwgQ8fLCBABRtMgs0GFxznQGr8APEbAf6RUIFmCSkmwgQeuKQbNxKc 4wEPAUywwXkGLEBOAwnsBcFWN+TSWQMIbBAfeU4EYA+IA/hTwAKTqJEBAhdoEMBJtFjQwQeFXPCA MfEdh8djCmyFQAQhAUABFqsw8I8BZ+xTnwsCWIABBhssEIFwEnCgSlLA8ECBcwZsAYEDEXhVQKAD RJDOTQkgUEEatrSXQAEOyDSTATwoc8imb3oDkJQXtTcmRQx+MRcF44lwgY0UOAABAjkN0JpqCnD1 SE4zNDVIFgLYVkBvFTiAgG8CIGBABQgYO0BVk9aoQRUOHDCAXxokgIGWA6NZYECNhBagwQALUOBR q78O8M4bxiJQqwEI2JmVAg4M0K0DlDLAgAIF/OFWAxQoYIEFBaQDVQeTWkGpAgswKYEF8i7gVbgb bPNGA78EXEEBHxgggTgCSHDBxkoIICuBISdQE20QnMxdqwNQQOkoAyRQ0gW/juIAuxdYEI0XnVrE T88k4CrNuRUVbfTRSCet9NJMNxECADs= ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://www.cancer.gov/stylesheets/nci.css BODY { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } TD { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } TABLE { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } P { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .text { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .gray { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.gray { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.gray:active { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.gray:visited { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.gray-link { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.gray-link:visited { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.gray-link:active { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.gray-text { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.gray-text:visited { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.gray-text:active { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } DIV { FONT-WEIGHT: normal; FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; TEXT-DECORATION: none } P { FONT-WEIGHT: normal; FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; TEXT-DECORATION: none } TD { FONT-WEIGHT: normal; FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; TEXT-DECORATION: none } UL { FONT-WEIGHT: normal; FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; TEXT-DECORATION: none } OL { FONT-WEIGHT: normal; FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; TEXT-DECORATION: none } LI { FONT-WEIGHT: normal; FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; TEXT-DECORATION: none } DL { FONT-WEIGHT: normal; FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; TEXT-DECORATION: none } TD { FONT-WEIGHT: normal; FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; TEXT-DECORATION: none } DD { FONT-WEIGHT: normal; FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; TEXT-DECORATION: none } .text { FONT-WEIGHT: normal; FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; TEXT-DECORATION: none } A.gray-link:hover { FONT-SIZE: 12px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif; TEXT-DECORATION: underline } A.gray-text:hover { FONT-SIZE: 12px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif; TEXT-DECORATION: underline } A.gray:hover { FONT-SIZE: 12px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif; TEXT-DECORATION: underline } .text-b { FONT-WEIGHT: bold; FONT-SIZE: 12px; FONT-FAMILY: Arial, Verdana, = Trebuchet MS, Tahoma, sans-serif } .gray-text-b { FONT-WEIGHT: bold; FONT-SIZE: 12px; FONT-FAMILY: Arial, Verdana, = Trebuchet MS, Tahoma, sans-serif } .section-title { FONT-WEIGHT: normal; FONT-SIZE: 24px; COLOR: #6e6c4f; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif } .document-title { FONT-WEIGHT: normal; FONT-SIZE: 19px; COLOR: #000000; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif } .page-title { FONT-WEIGHT: bold; FONT-SIZE: 17px; COLOR: #000000; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } H2 { FONT-WEIGHT: bold; FONT-SIZE: 17px; COLOR: #000000; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } .DrugInfoSummary-SummarySection-Title-Level1 { FONT-WEIGHT: bold; FONT-SIZE: 17px; COLOR: #000000; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } .header-A { FONT-WEIGHT: bold; FONT-SIZE: 14px; COLOR: #000000; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } H3 { FONT-WEIGHT: bold; FONT-SIZE: 14px; COLOR: #000000; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } .header-B { FONT-WEIGHT: bold; FONT-SIZE: 12px; COLOR: #000000; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } H4 { FONT-WEIGHT: bold; FONT-SIZE: 12px; COLOR: #000000; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } .header-C { FONT-WEIGHT: bold; FONT-SIZE: 12px; FONT-FAMILY: Arial, Verdana, = Trebuchet MS, Tahoma, sans-serif } .header-D { FONT-WEIGHT: bold; FONT-SIZE: 12px; FONT-STYLE: italic; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif } A { FONT-SIZE: 12px; COLOR: #9c3303; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A:active { FONT-SIZE: 12px; COLOR: #9c3303; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A:visited { FONT-SIZE: 12px; COLOR: #9c3303; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .red-text { FONT-SIZE: 12px; COLOR: #9c3303; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A:hover { FONT-SIZE: 12px; COLOR: #990000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif; TEXT-DECORATION: underline } A.backtotop-link { FONT-SIZE: 11px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif; TEXT-DECORATION: underline } A.backtotop-link:visited { FONT-SIZE: 11px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif; TEXT-DECORATION: underline } A.backtotop-link:active { FONT-SIZE: 11px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif; TEXT-DECORATION: underline } A.backtotop-link:hover { COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, = sans-serif; TEXT-DECORATION: underline } IMG { BORDER-RIGHT: 0px; BORDER-TOP: 0px; BORDER-LEFT: 0px; BORDER-BOTTOM: = 0px } IMG.right { BORDER-RIGHT: 0px; BORDER-TOP: 0px; MARGIN-BOTTOM: 10px; MARGIN-LEFT: = 10px; BORDER-LEFT: 0px; BORDER-BOTTOM: 0px } IMG.left { BORDER-RIGHT: 0px; BORDER-TOP: 0px; MARGIN-BOTTOM: 10px; BORDER-LEFT: = 0px; MARGIN-RIGHT: 10px; BORDER-BOTTOM: 0px } IMG.center { DISPLAY: block; MARGIN-LEFT: auto; MARGIN-RIGHT: auto } .hide { DISPLAY: none } .hr-es { BORDER-RIGHT: 0px; PADDING-RIGHT: 0px; BORDER-TOP: 0px; PADDING-LEFT: = 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; BORDER-LEFT: 0px; COLOR: #d7d7d7; = PADDING-TOP: 0px; BORDER-BOTTOM: 0px; HEIGHT: 1px; BACKGROUND-COLOR: = #d7d7d7 } .cancer-bulletin-homepage-story-title { FONT-SIZE: 22px; COLOR: #b50000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, sans-serif; TEXT-DECORATION: none } .cancer-bulletin-subpage-story-title { FONT-SIZE: 19px; COLOR: #b50000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, sans-serif; TEXT-DECORATION: none } .cancer-bulletin-header-text { FONT-SIZE: 11px; COLOR: #ffffff; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, sans-serif; TEXT-DECORATION: none } A.cancer-bulletin-header-text { FONT-SIZE: 11px; COLOR: #ffffff; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, sans-serif; TEXT-DECORATION: underline } A.cancer-bulletin-header-text:link { FONT-SIZE: 11px; COLOR: #ffffff; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, sans-serif; TEXT-DECORATION: underline } A.cancer-bulletin-header-text:active { FONT-SIZE: 11px; COLOR: #ffffff; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, sans-serif; TEXT-DECORATION: underline } A.cancer-bulletin-header-text:visited { FONT-SIZE: 11px; COLOR: #ffffff; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, sans-serif; TEXT-DECORATION: underline } A.cancer-bulletin-header-text:hover { FONT-SIZE: 11px; COLOR: #ffffff; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, sans-serif; TEXT-DECORATION: underline } A.definition { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif; TEXT-DECORATION: underline } A.definition:visited { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif; TEXT-DECORATION: underline } A.definition:active { FONT-SIZE: 12px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif; TEXT-DECORATION: underline } A.definition:hover { FONT-SIZE: 12px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif; TEXT-DECORATION: underline } .gray-border { BACKGROUND-COLOR: #bdbdbd } .directors-corner-contentarea { FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; = BACKGROUND-COLOR: #f7f7f5 } A.footer-link { FONT-SIZE: 11px; COLOR: #666666; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.footer-link:visited { FONT-SIZE: 11px; COLOR: #666666; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.footer-link:active { FONT-SIZE: 11px; COLOR: #666666; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .footer-text { FONT-SIZE: 11px; COLOR: #666666; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.footer-link:hover { FONT-SIZE: 11px; COLOR: #333333; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .search-field { WIDTH: 120px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif; HEIGHT: 22px } .leftnav { FONT-SIZE: 11px; FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, = sans-serif } .box-title { FONT-WEIGHT: bold; COLOR: #000000; FONT-FAMILY: Arial, Verdana, = Trebuchet MS, Tahoma, sans-serif; BACKGROUND-COLOR: #e6e6e2; = TEXT-DECORATION: none } A.box-title { FONT-WEIGHT: bold; COLOR: #000000; FONT-FAMILY: Arial, Verdana, = Trebuchet MS, Tahoma, sans-serif; BACKGROUND-COLOR: #e6e6e2; = TEXT-DECORATION: none } A.box-title:link { FONT-WEIGHT: bold; COLOR: #000000; FONT-FAMILY: Arial, Verdana, = Trebuchet MS, Tahoma, sans-serif; BACKGROUND-COLOR: #e6e6e2; = TEXT-DECORATION: none } A.box-title:active { FONT-WEIGHT: bold; COLOR: #000000; FONT-FAMILY: Arial, Verdana, = Trebuchet MS, Tahoma, sans-serif; BACKGROUND-COLOR: #e6e6e2; = TEXT-DECORATION: none } A.box-title:visited { FONT-WEIGHT: bold; COLOR: #000000; FONT-FAMILY: Arial, Verdana, = Trebuchet MS, Tahoma, sans-serif; BACKGROUND-COLOR: #e6e6e2; = TEXT-DECORATION: none } A.box-title:hover { FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; = TEXT-DECORATION: underline } .leftnav-shaded-box { BORDER-RIGHT: #bdbdbd 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: = #bdbdbd 1px solid; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px = 0px 6px; BORDER-LEFT: #bdbdbd 1px solid; PADDING-TOP: 0px; = BORDER-BOTTOM: #bdbdbd 1px solid; LIST-STYLE-TYPE: none } .leftnav-shaded-box H1 { PADDING-RIGHT: 7px; PADDING-LEFT: 7px; FONT-WEIGHT: bold; FONT-SIZE: = 12px; PADDING-BOTTOM: 3px; MARGIN: 0px; COLOR: #000000; LINE-HEIGHT: = 13px; PADDING-TOP: 3px; FONT-FAMILY: Arial, Verdana, Trebuchet MS, = Tahoma, sans-serif; BACKGROUND-COLOR: #dadada } .leftnav-shaded-box UL { BORDER-RIGHT: 0px; BORDER-TOP: 0px; MARGIN: 0px; BORDER-LEFT: 0px; = BORDER-BOTTOM: 0px; LIST-STYLE-TYPE: none } .leftnav-shaded-box UL LI { PADDING-RIGHT: 5px; BORDER-TOP: #bdbdbd 1px solid; DISPLAY: block; = PADDING-LEFT: 18px; BACKGROUND: url(../images/left-nav-red-arrow.gif) = #eaebe6 no-repeat 7px 10px; LIST-STYLE-IMAGE: url(/images/spacer.gif); = PADDING-BOTTOM: 5px; MARGIN: 0px; FONT: 12px Arial, Helvetica, = sans-serif; PADDING-TOP: 5px; LIST-STYLE-TYPE: none } .leftnav-shaded-box UL LI A:link { COLOR: #1a1a1a; TEXT-DECORATION: none } .leftnav-shaded-box UL LI A:visited { COLOR: #1a1a1a; TEXT-DECORATION: none } .leftnav-shaded-box UL LI A:active { COLOR: #1a1a1a; TEXT-DECORATION: none } .leftnav-shaded-box UL LI A:hover { TEXT-DECORATION: underline } .navigation-white { FONT-SIZE: 11px; COLOR: #fff } TD.navigation-white { FONT-SIZE: 11px; COLOR: #fff } A.navigation-white:link { FONT-SIZE: 11px; COLOR: #fff } A.navigation-white:visited { FONT-SIZE: 11px; COLOR: #fff } A.navigation-white:active { FONT-SIZE: 11px; COLOR: #fff } A.navigation-white:hover { COLOR: #f1efef } .navigation-gray { FONT-SIZE: 11px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-gray { FONT-SIZE: 11px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-gray:visited { FONT-SIZE: 11px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-gray:active { FONT-SIZE: 11px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-gray-link { FONT-SIZE: 11px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-gray-link:visited { FONT-SIZE: 11px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-gray-link:active { FONT-SIZE: 11px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-gray-link:hover { FONT-SIZE: 11px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-gray:hover { FONT-SIZE: 11px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .navigation-selected { FONT-SIZE: 11px; COLOR: #999999; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .navigation-dark-gray { FONT-SIZE: 11px; COLOR: #333333; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-dark-gray-link { FONT-SIZE: 11px; COLOR: #333333; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-dark-gray-link:visited { FONT-SIZE: 11px; COLOR: #333333; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-dark-gray-link:active { FONT-SIZE: 11px; COLOR: #333333; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .navigation-black { FONT-SIZE: 11px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-black-link { FONT-SIZE: 11px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-black-link:visited { FONT-SIZE: 11px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-black-link:active { FONT-SIZE: 11px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-black-link:hover { FONT-SIZE: 11px; COLOR: #333333; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-dark-gray-link:hover { FONT-SIZE: 11px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .navigation-dark-red { FONT-SIZE: 11px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-dark-red { FONT-SIZE: 11px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-dark-red:link { FONT-SIZE: 11px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-dark-red:active { FONT-SIZE: 11px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-dark-red:visited { FONT-SIZE: 11px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-dark-red-link { FONT-SIZE: 11px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-dark-red-link:visited { FONT-SIZE: 11px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-dark-red-link:active { FONT-SIZE: 11px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-dark-red-link:hover { FONT-SIZE: 11px; COLOR: #990000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.navigation-dark-red:hover { FONT-SIZE: 11px; COLOR: #990000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .red-header { FONT-WEIGHT: bold; FONT-SIZE: 13px; COLOR: #cc0000; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } A.red-header { FONT-WEIGHT: bold; FONT-SIZE: 13px; COLOR: #cc0000; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } A.red-header:visited { FONT-WEIGHT: bold; FONT-SIZE: 13px; COLOR: #cc0000; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } A.red-header:active { FONT-WEIGHT: bold; FONT-SIZE: 13px; COLOR: #cc0000; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } A.red-header:hover { FONT-WEIGHT: bold; FONT-SIZE: 13px; COLOR: #990000; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } .dark-red { COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, = sans-serif } A.dark-red-link { COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, = sans-serif } A.dark-red-link:visited { COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, = sans-serif } A.dark-red-link:active { COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, = sans-serif } A.dark-red-link:hover { FONT-SIZE: 11px; COLOR: #990000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .black-text { FONT-SIZE: 12px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.black-text { FONT-SIZE: 12px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.black-text:visited { FONT-SIZE: 12px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.black-text:active { FONT-SIZE: 12px; COLOR: #000000; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .black-text-b { FONT-WEIGHT: bold; FONT-SIZE: 12px; COLOR: #000000; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } A.black-text:hover { FONT-SIZE: 12px; COLOR: #333333; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .quote { FONT-WEIGHT: bold; FONT-SIZE: 12px; COLOR: #996666; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } .caption { FONT-SIZE: 11px; COLOR: #4d4d4d; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .caption-image { BORDER-RIGHT: #bdbdbd 0px solid; BORDER-TOP: #bdbdbd 0px solid; = BORDER-LEFT: #bdbdbd 0px solid; BORDER-BOTTOM: #bdbdbd 1px solid } .dates { FONT-SIZE: 11px; FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, = sans-serif } .protocol-date-label { FONT-WEIGHT: bold; FONT-SIZE: 11px; FONT-FAMILY: Arial, Verdana, = Trebuchet MS, Tahoma, sans-serif } .protocol-dates { FONT-SIZE: 11px; FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, = sans-serif } SUP.header { FONT-SIZE: 13px; FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, = sans-serif } .dictionary-alpha-list { PADDING-RIGHT: 4px; PADDING-LEFT: 4px; FONT-SIZE: 11px; PADDING-BOTTOM: = 6px; VERTICAL-ALIGN: middle; COLOR: #a90101; PADDING-TOP: 6px; = FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; HEIGHT: = 16px } A.dictionary-alpha-list { PADDING-RIGHT: 4px; PADDING-LEFT: 4px; FONT-SIZE: 11px; PADDING-BOTTOM: = 6px; VERTICAL-ALIGN: middle; COLOR: #a90101; PADDING-TOP: 6px; = FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; HEIGHT: = 16px } A.dictionary-alpha-list:link { PADDING-RIGHT: 4px; PADDING-LEFT: 4px; FONT-SIZE: 11px; PADDING-BOTTOM: = 6px; VERTICAL-ALIGN: middle; COLOR: #a90101; PADDING-TOP: 6px; = FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; HEIGHT: = 16px } A.dictionary-alpha-list:active { PADDING-RIGHT: 4px; PADDING-LEFT: 4px; FONT-SIZE: 11px; PADDING-BOTTOM: = 6px; VERTICAL-ALIGN: middle; COLOR: #a90101; PADDING-TOP: 6px; = FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; HEIGHT: = 16px } A.dictionary-alpha-list:visited { PADDING-RIGHT: 4px; PADDING-LEFT: 4px; FONT-SIZE: 11px; PADDING-BOTTOM: = 6px; VERTICAL-ALIGN: middle; COLOR: #a90101; PADDING-TOP: 6px; = FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; HEIGHT: = 16px } A.dictionary-alpha-list:hover { PADDING-RIGHT: 4px; PADDING-LEFT: 4px; FONT-SIZE: 11px; PADDING-BOTTOM: = 6px; VERTICAL-ALIGN: middle; COLOR: #a90101; PADDING-TOP: 6px; = FONT-FAMILY: Arial, Verdana, Trebuchet MS, Tahoma, sans-serif; HEIGHT: = 16px; BACKGROUND-COLOR: #ffffff } .dictionary-partial-match { FONT-WEIGHT: bold; FONT-SIZE: 12px; BACKGROUND-IMAGE: = url(../images/dictionary-ext-mtc-bg.gif); COLOR: #993300; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif } A.dictionary-partial-match { FONT-WEIGHT: bold; FONT-SIZE: 12px; BACKGROUND-IMAGE: = url(../images/dictionary-ext-mtc-bg.gif); COLOR: #993300; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif } A.dictionary-partial-match:link { FONT-WEIGHT: bold; FONT-SIZE: 12px; BACKGROUND-IMAGE: = url(../images/dictionary-ext-mtc-bg.gif); COLOR: #993300; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif } A.dictionary-partial-match:active { FONT-WEIGHT: bold; FONT-SIZE: 12px; BACKGROUND-IMAGE: = url(../images/dictionary-ext-mtc-bg.gif); COLOR: #993300; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif } A.dictionary-partial-match:visited { FONT-WEIGHT: bold; FONT-SIZE: 12px; BACKGROUND-IMAGE: = url(../images/dictionary-ext-mtc-bg.gif); COLOR: #993300; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif } A.dictionary-partial-match:hover { FONT-WEIGHT: bold; FONT-SIZE: 12px; BACKGROUND-IMAGE: = url(images/dictionary-ext-mtc-bg.gif); COLOR: #993300; FONT-FAMILY: = Arial, Verdana, Trebuchet MS, Tahoma, sans-serif } .dictionary-partial-match-n { FONT-SIZE: 12px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.dictionary-partial-match-n { FONT-SIZE: 12px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.dictionary-partial-match-n:link { FONT-SIZE: 12px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.dictionary-partial-match-n:active { FONT-SIZE: 12px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.dictionary-partial-match-n:visited { FONT-SIZE: 12px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } A.dictionary-partial-match-n:hover { FONT-SIZE: 12px; COLOR: #993300; FONT-FAMILY: Arial, Verdana, Trebuchet = MS, Tahoma, sans-serif } .search-result { FONT-WEIGHT: bold; FONT-SIZE: 17px; COLOR: #646464; FONT-FAMILY: Arial, = Verdana, Trebuchet MS, Tahoma, sans-serif } .content-gray-background { PADDING-RIGHT: 12px; PADDING-LEFT: 12px; BACKGROUND: #f5f5f3; = PADDING-BOTTOM: 20px; PADDING-TOP: 14px } .pdq-shaded-area { PADDING-RIGHT: 12px; PADDING-LEFT: 12px; BACKGROUND: #f5f5f3; = PADDING-BOTTOM: 20px; PADDING-TOP: 14px } .note { PADDING-RIGHT: 0px; BORDER-TOP: #d3d3d3 1px solid; PADDING-LEFT: 0px; = PADDING-BOTTOM: 18px; PADDING-TOP: 18px; BORDER-BOTTOM: #d3d3d3 1px = solid } .druginfosummarybox { BORDER-RIGHT: #c9cace 1px solid; PADDING-RIGHT: 16px; BORDER-TOP: = #c9cace 1px solid; PADDING-LEFT: 16px; PADDING-BOTTOM: 16px; MARGIN: = 0px; BORDER-LEFT: #c9cace 1px solid; WIDTH: 516px; PADDING-TOP: 16px; = BORDER-BOTTOM: #c9cace 1px solid; BACKGROUND-COLOR: #eff2f7; = voice-family: inherit } .Protocol-Title { FONT-WEIGHT: bold; FONT-SIZE: 17px; COLOR: #000000 } .Protocol-OfficialTitle { FONT-WEIGHT: bold; FONT-SIZE: 16px; COLOR: #000000; LINE-HEIGHT: 18px } A.Protocol-TOC-Link { COLOR: #9c3303 } A.Protocol-TOC-Link:visited { COLOR: #9c3303 } A.Protocol-TOC-Link:active { COLOR: #9c3303 } A.Protocol-TOC-Link:hover { COLOR: #990000; TEXT-DECORATION: underline } .Protocol-TOC-SubLink { TEXT-DECORATION: none } .Protocol-Section-Heading { FONT-WEIGHT: bold; FONT-SIZE: 14px; COLOR: #000000 } .Protocol-Section-SubHeading { FONT-WEIGHT: bold; FONT-SIZE: 14px; COLOR: #000000 } .Protocol-PublishedResults-PUBMED { FONT-SIZE: 10px } .Protocol-DownloadDate { FONT-WEIGHT: bold } .Protocol-BasicStudy-Grayborder { BACKGROUND-COLOR: #bdbdbd } .Protocol-LeadOrg-OrgName { FONT-WEIGHT: bold } .Protocol-BasicStudy-TD-Grayborder { BACKGROUND-COLOR: #bdbdbd } .Protocol-BasicStudy-Heading { FONT-WEIGHT: bold } .Protocol-BasicStudy-PrimaryID { FONT-WEIGHT: bold } .Protocol-BasicStudy-AlternateID { FONT-SIZE: 10px } .Protocol-Term-SubHeading { FONT-WEIGHT: bold } .Protocol-Term-Table-Heading { FONT-WEIGHT: bold } .Protocol-EntryCriteria-DiseaseCharacteristics { FONT-WEIGHT: bold } .Protocol-EntryCriteria-PatientCharacteristics { FONT-WEIGHT: bold } .Protocol-EntryCriteria-PriorConcurrentTherapy { FONT-WEIGHT: bold } .Protocol-EntryCriteria-GeneralEligibilityCriteria { FONT-WEIGHT: bold } .Protocol-Outcomes-Primary { FONT-WEIGHT: bold; FONT-STYLE: italic } .Protocol-country { FONT-WEIGHT: bold; FONT-SIZE: 14px; COLOR: #000000; LINE-HEIGHT: 18px; = BACKGROUND-COLOR: #e6e6e2 } .Protocol-Site-CountryName { FONT-WEIGHT: bold; FONT-SIZE: 14px; COLOR: #000000; LINE-HEIGHT: 18px; = BACKGROUND-COLOR: #e6e6e2 } .Protocol-Site-Country { FONT-WEIGHT: bold; FONT-SIZE: 14px; COLOR: #000000; LINE-HEIGHT: 18px; = BACKGROUND-COLOR: #e6e6e2 } .Protocol-state { FONT-WEIGHT: bold; FONT-SIZE: 14px; COLOR: #993333 } .Protocol-Site-StateName { FONT-WEIGHT: bold; FONT-SIZE: 14px; COLOR: #993333 } .Protocol-Site-State { FONT-WEIGHT: bold; FONT-SIZE: 14px; COLOR: #993333 } .Protocol-city { FONT-WEIGHT: bold } Protocol-Site-City { FONT-WEIGHT: bold } .Protocol-Site-SiteName { FONT-WEIGHT: bold; FONT-STYLE: italic } .Protocol-Purpose { FONT-WEIGHT: bold } .Protocol-EligibilityText { FONT-WEIGHT: bold } .Protocol-TreatmentIntervention { FONT-WEIGHT: bold } .Protocol-PatientDisclaimer { FONT-WEIGHT: bold } .Protocol-LI-Title { FONT-WEIGHT: bold; FONT-STYLE: italic } .Protocol-IL-Title { FONT-WEIGHT: bold; FONT-STYLE: italic } .protocol-primaryprotocolid { FONT-WEIGHT: bold } .Protocol-OL-Title { FONT-WEIGHT: bold; FONT-STYLE: italic } LI.Protocol-LI { LIST-STYLE-IMAGE: none; LIST-STYLE-TYPE: disc } LI.Protocol-IL-Bullet { LIST-STYLE-IMAGE: none; LIST-STYLE-TYPE: disc } LI.Protocol-IL-Dash { LIST-STYLE-IMAGE: none; LIST-STYLE-TYPE: square } LI.Protocol-IL-Circle { LIST-STYLE-IMAGE: none; LIST-STYLE-TYPE: none } LI.Protocol-IL-Simple { LIST-STYLE-IMAGE: none; LIST-STYLE-TYPE: none } LI.Protocol-OL-Lroman { LIST-STYLE-IMAGE: none; LIST-STYLE-TYPE: lower-roman } LI.Protocol-OL-Uroman { LIST-STYLE-IMAGE: none; LIST-STYLE-TYPE: upper-roman } LI.Protocol-OL-Lalpha { LIST-STYLE-IMAGE: none; LIST-STYLE-TYPE: lower-alpha } LI.Protocol-OL-Ualpha { LIST-STYLE-IMAGE: none; LIST-STYLE-TYPE: upper-alpha } LI.Protocol-OL-Arabic { LIST-STYLE-IMAGE: none; LIST-STYLE-TYPE: decimal } OL.Protocol-KeyPoints-Bullet { LIST-STYLE-TYPE: disc } OL.Protocol-KeyPoints-Dash { LIST-STYLE-TYPE: square } LI.CDR { MARGIN-TOP: 5px; PADDING-LEFT: 5px; FONT-SIZE: 13px; LIST-STYLE-IMAGE: = none; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 0px; LINE-HEIGHT: 16px } .Protocol-ScientificName { FONT-STYLE: italic } .Protocol-ForeignWord { FONT-STYLE: italic } .Protocol-GeneName { FONT-STYLE: italic } .Protocol-Note { FONT-STYLE: italic } .page-title-summary { FONT-WEIGHT: bold; FONT-SIZE: 17px; FLOAT: left; WIDTH: 100%; COLOR: = #000000 } .Summary-Title { FONT-WEIGHT: normal; FONT-SIZE: 19px; COLOR: #000000 } .Summary-SummaryTitle { FONT-WEIGHT: bold } LI.Summary-SummaryTitle-Level1 { FONT-WEIGHT: bold; FONT-SIZE: 14px; COLOR: #000000 } LI.Summary-SummaryTitle-Level2 { FONT-WEIGHT: bold; FONT-SIZE: 12px; COLOR: #000000 } LI.Summary-SummaryTitle-Level3 { FONT-WEIGHT: bold } .Summary-SummarySection-Title-Level1 { FONT-WEIGHT: normal; FONT-SIZE: 19px; COLOR: #000000 } .Summary-SummarySection-Title-Level2 { FONT-WEIGHT: bold; FONT-SIZE: 14px; COLOR: #000000 } .Summary-SummarySection-Title-Level3 { FONT-WEIGHT: bold; FONT-SIZE: 12px; COLOR: #000000 } .Summary-SummarySection-Title-Level4 { FONT-WEIGHT: bold } .Summary-SummarySection-Keypoint-Title { FONT-WEIGHT: bold; BACKGROUND-COLOR: #d4d9d9; TEXT-ALIGN: center } .Summary-SummarySection-Small { FONT-SIZE: 7pt } .Summary-Table-Caption { FONT-SIZE: 15px; COLOR: #000000 } UL.SummarySection-KeyPoint-UL-Dash { LIST-STYLE-TYPE: square } UL.SummarySection-KeyPoint-UL-Bullet { LIST-STYLE-TYPE: disc } LI.SummarySection-KeyPoint-LI { MARGIN-TOP: 5px; PADDING-LEFT: 5px; FONT-SIZE: 13px; LIST-STYLE-IMAGE: = none; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 0px; COLOR: #000000; LINE-HEIGHT: = 16px } .Summary-ReferenceSection { FONT-WEIGHT: bold } .Summary-Citation-PUBMED { FONT-SIZE: 10px } .Summary-KeyPoint { FONT-WEIGHT: bold; FONT-SIZE: 14px; COLOR: #000000 } .Summary-ProfessionalDisclaimer-Title { FONT-WEIGHT: bold } .Summary-ProfessionalDisclaimer { FONT-STYLE: italic } A.Summary-GlossaryTermRef { COLOR: #4d4d4d; TEXT-DECORATION: underline } A.Summary-GlossaryTermRef:visited { COLOR: #4d4d4d; TEXT-DECORATION: underline } A.Summary-GlossaryTermRef:active { COLOR: #4d4d4d; TEXT-DECORATION: underline } A.Protocol-GlossaryTermRef { COLOR: #4d4d4d; TEXT-DECORATION: underline } A.Protocol-GlossaryTermRef:active { COLOR: #4d4d4d; TEXT-DECORATION: underline } A.Protocol-GlossaryTermRef:visited { COLOR: #4d4d4d; TEXT-DECORATION: underline } A.Summary-GlossaryTermRef:hover { COLOR: #000000; TEXT-DECORATION: underline } A.Protocol-GlossaryTermRef:hover { COLOR: #000000; TEXT-DECORATION: underline } P.graytext { COLOR: #666666 } P.blacktext { COLOR: #000000 } P.block { MARGIN: 10px 20px } TD.rightnav { FONT-SIZE: 12px } TD.rightnav A { FONT-SIZE: 12px } A.footer { COLOR: #000000; TEXT-DECORATION: none } A.footer:visited { COLOR: #666699; TEXT-DECORATION: none } A.footer:hover { COLOR: #669999; TEXT-DECORATION: none } A.whitetab { FONT-SIZE: 11px; COLOR: #336; LINE-HEIGHT: 10px; TEXT-DECORATION: none } A.whiteslanttab { FONT-SIZE: 11px; COLOR: #336; LINE-HEIGHT: 10px; FONT-STYLE: italic; = TEXT-DECORATION: none } A.whitetab:visited { FONT-SIZE: 11px; COLOR: #336; LINE-HEIGHT: 10px; TEXT-DECORATION: none } A.whiteslanttab:visited { FONT-SIZE: 11px; COLOR: #336; LINE-HEIGHT: 10px; FONT-STYLE: italic; = TEXT-DECORATION: none } A.whitetab:hover { FONT-SIZE: 11px; COLOR: #669999; LINE-HEIGHT: 10px; TEXT-DECORATION: = none } A.whiteslanttab:hover { FONT-SIZE: 11px; COLOR: #669999; LINE-HEIGHT: 10px; FONT-STYLE: italic; = TEXT-DECORATION: none } A.alpha { FONT-WEIGHT: bold; FONT-SIZE: 13px; COLOR: #000000; LINE-HEIGHT: 13px; = TEXT-DECORATION: underline } A.alpha:visited { COLOR: #666699; TEXT-DECORATION: underline } A.alpha:hover { COLOR: #669999; TEXT-DECORATION: underline } .footer { FONT-SIZE: 13px; COLOR: #000000; TEXT-DECORATION: none } .field { FONT-SIZE: 8pt; COLOR: #000000; HEIGHT: 22px } .font_field { FONT-SIZE: 8pt; COLOR: #000000 } .size7_field { FONT-SIZE: 8pt; WIDTH: 69px; COLOR: #000000; HEIGHT: 22px } .size10_field { FONT-SIZE: 8pt; WIDTH: 69px; COLOR: #000000; HEIGHT: 18px } .size12_field { FONT-SIZE: 8pt; WIDTH: 100px; COLOR: #000000; HEIGHT: 22px } .size14_field { FONT-SIZE: 8pt; WIDTH: 138px; COLOR: #000000; HEIGHT: 22px } .size30_field { FONT-SIZE: 8pt; WIDTH: 180px; COLOR: #000000; HEIGHT: 22px } .size30x3_field { FONT-SIZE: 8pt; WIDTH: 180px; COLOR: #000000; HEIGHT: 60px } .size40_field { FONT-SIZE: 8pt; WIDTH: 240px; COLOR: #000000; HEIGHT: 22px } .size40x3_field { FONT-SIZE: 8pt; WIDTH: 240px; COLOR: #000000; HEIGHT: 60px } .size50_field { FONT-SIZE: 8pt; WIDTH: 300px; COLOR: #000000; HEIGHT: 22px } .size50x3_field { FONT-SIZE: 8pt; WIDTH: 300px; COLOR: #000000; HEIGHT: 60px } .size60x3_field { FONT-SIZE: 8pt; WIDTH: 360px; COLOR: #000000; HEIGHT: 60px } .header1 { FONT-WEIGHT: bold; FONT-SIZE: 16px; COLOR: #000000; LINE-HEIGHT: 18px } H1 { FONT-WEIGHT: bold; FONT-SIZE: 16px; COLOR: #000000; LINE-HEIGHT: 18px } .pressh1 { FONT-WEIGHT: bold; FONT-SIZE: 15px; COLOR: #000000; LINE-HEIGHT: 18px } .header1black { FONT-WEIGHT: bold; FONT-SIZE: 16px; COLOR: #000; LINE-HEIGHT: 18px } .header2 { FONT-WEIGHT: bold; FONT-SIZE: 15px; COLOR: #000000; LINE-HEIGHT: 16px } H2.header2 { FONT-WEIGHT: bold; FONT-SIZE: 15px; MARGIN: 4px; COLOR: #000000; = LINE-HEIGHT: 16px } PRE { FONT-SIZE: 11px } .fake_H2 { FONT-WEIGHT: bold; FONT-SIZE: 15px; COLOR: #000000; LINE-HEIGHT: 16px } H1.CDR { FONT-WEIGHT: bold; FONT-SIZE: 17px; COLOR: #000000; LINE-HEIGHT: 18px } H2.CDR { FONT-WEIGHT: bold; FONT-SIZE: large; COLOR: #000000; LINE-HEIGHT: = normal } H3.CDR { FONT-WEIGHT: bold; FONT-SIZE: medium; COLOR: #000000 } H4.CDR { FONT-WEIGHT: bold; FONT-SIZE: small; COLOR: #000000 } H1.OESI { MARGIN-TOP: 0%; FONT-WEIGHT: normal; FONT-SIZE: 24pt; MARGIN-BOTTOM: = 0%; COLOR: #000000; FONT-FAMILY: Times New Roman } H2.OESI { MARGIN-TOP: 0%; FONT-WEIGHT: normal; FONT-SIZE: 14pt; MARGIN-BOTTOM: = 0%; COLOR: #666699; FONT-FAMILY: Times New Roman; FONT-VARIANT: = small-caps } .oesi_desc { LINE-HEIGHT: 15px } H1.digest { MARGIN-TOP: 0%; FONT-SIZE: 16pt; MARGIN-BOTTOM: 0%; COLOR: #000000; = LINE-HEIGHT: normal } .digest_header { MARGIN-TOP: 0%; FONT-WEIGHT: bold; FONT-SIZE: 16pt; MARGIN-BOTTOM: 0%; = COLOR: #000000; LINE-HEIGHT: normal } .header-text { FONT-SIZE: 20px; COLOR: #ffffff } .graytext { COLOR: #666666 } .whitetext { COLOR: #ffffff } .bigwhite { FONT-WEIGHT: bold; FONT-SIZE: 16px; COLOR: #ffffff } .blacktext { COLOR: #000000 } .toc H2 { MARGIN-TOP: 0px; FONT-WEIGHT: bold; FONT-SIZE: 15px; MARGIN-BOTTOM: = 3px; COLOR: #000000 } .toc H3 { MARGIN-TOP: 0px; FONT-WEIGHT: bold; FONT-SIZE: 14px; MARGIN-BOTTOM: = 3px; COLOR: #000000 } .toc H4 { MARGIN-TOP: 0px; FONT-WEIGHT: bold; FONT-SIZE: 13px; MARGIN-BOTTOM: = 3px; COLOR: #000000 } .toc H5 { MARGIN-TOP: 0px; FONT-WEIGHT: bold; FONT-SIZE: 13px; MARGIN-BOTTOM: = 3px; COLOR: #000000 } .toc H6 { MARGIN-TOP: 0px; FONT-WEIGHT: bold; FONT-SIZE: 13px; MARGIN-BOTTOM: = 3px; COLOR: #000000 } H5 { FONT-WEIGHT: bold; FONT-SIZE: 13px; COLOR: #000000 } H6 { FONT-WEIGHT: bold; FONT-SIZE: 13px; COLOR: #000000 } LI.portal { MARGIN-TOP: 5px; PADDING-LEFT: 0px; LIST-STYLE-IMAGE: = url(/images/bullet_sm_css.gif); MARGIN-BOTTOM: 0px; MARGIN-LEFT: 0px; = LINE-HEIGHT: 11px } LI.sub { MARGIN-TOP: 5px; PADDING-LEFT: 0px; FONT-SIZE: 13px; LIST-STYLE-IMAGE: = url(/images/bullet_sm_css.gif); MARGIN-BOTTOM: 5px; MARGIN-LEFT: 5px; = COLOR: #000; LINE-HEIGHT: 16px } .pdq P { MARGIN-TOP: 0px; FONT-SIZE: 13px; LEFT: 20px; MARGIN-BOTTOM: 10px; = PADDING-BOTTOM: 0px; COLOR: #000000; PADDING-TOP: 2px; POSITION: = relative } .pdq H2 { MARGIN-TOP: 0px; FONT-WEIGHT: bold; FONT-SIZE: 15px; MARGIN-BOTTOM: = 0px; PADDING-BOTTOM: 0px; COLOR: #000000; PADDING-TOP: 0px } .pdq H3 { MARGIN-TOP: 0px; FONT-WEIGHT: bold; FONT-SIZE: 14px; MARGIN-BOTTOM: = 0px; PADDING-BOTTOM: 0px; COLOR: #000000; PADDING-TOP: 10px } .pdq H4 { MARGIN-TOP: 0px; FONT-WEIGHT: bold; FONT-SIZE: 13px; MARGIN-BOTTOM: = 0px; PADDING-BOTTOM: 0px; MARGIN-LEFT: 15px; COLOR: #333366; = PADDING-TOP: 10px } .pdq UL { PADDING-RIGHT: 40px; MARGIN-TOP: 5px; PADDING-LEFT: 5px; LEFT: 25px; = MARGIN-BOTTOM: 5px; PADDING-BOTTOM: 5px; MARGIN-LEFT: 0px; PADDING-TOP: = 0px; POSITION: relative } .pdq UL LI { MARGIN-TOP: 0px; PADDING-LEFT: 5px; LIST-STYLE-IMAGE: = url(/images/bullet_sm.gif); MARGIN-BOTTOM: 0px; PADDING-BOTTOM: 2px; = MARGIN-LEFT: 0px; PADDING-TOP: 2px } .bullet { TEXT-DECORATION: none } .livehelpbutton { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND-IMAGE: = url(/images/livehelp_button.gif); PADDING-BOTTOM: 0px; WIDTH: 121px; = BORDER-TOP-STYLE: none; PADDING-TOP: 0px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 50px; BORDER-BOTTOM-STYLE: none } .textbutton { FONT-SIZE: 11px; COLOR: white } .PUBMED { FONT-SIZE: 10px } .oc_section_head { FONT-WEIGHT: bold; FONT-SIZE: 14pt; TEXT-TRANSFORM: none; COLOR: = #996600; LINE-HEIGHT: 16pt; FONT-STYLE: normal; FONT-VARIANT: normal; = TEXT-DECORATION: none } .oc_content_HEAD { FONT-WEIGHT: bold; FONT-SIZE: 12pt; TEXT-TRANSFORM: none; COLOR: = #000000; LINE-HEIGHT: 14pt; FONT-STYLE: normal; FONT-VARIANT: normal; = TEXT-DECORATION: none } .oc_backtotop { LIST-STYLE: none url(/images/oc_bullet.gif) outside; FONT-WEIGHT: bold; = FONT-SIZE: 10pt; COLOR: #996633; LINE-HEIGHT: normal; FONT-STYLE: = normal; TEXT-DECORATION: underline } .occontent { FONT-SIZE: 13pt; COLOR: #666666 } .graytextCopy { LIST-STYLE: none url(/images/oc_bullet.gif) outside; FONT-SIZE: 13px; = COLOR: #666666 } .oc_list { LIST-STYLE: none url(/images/oc_bullet.gif) outside; FONT-SIZE: 13px; = COLOR: #333333 } A.ns-leftnav { COLOR: #0033cc; TEXT-DECORATION: none } A.ns-leftnav:visited { COLOR: #0033cc; TEXT-DECORATION: none } A.ns-leftnav:hover { COLOR: #669999; TEXT-DECORATION: underline } .ns-section { FONT-WEIGHT: bold; FONT-SIZE: 13px; COLOR: #323264; TEXT-DECORATION: = none } A.ns-section { FONT-WEIGHT: bold; FONT-SIZE: 13px; COLOR: #323264; TEXT-DECORATION: = underline } A.ns-section:visited { FONT-WEIGHT: bold; FONT-SIZE: 13px; COLOR: #323264; TEXT-DECORATION: = underline } A.ns-section:hover { FONT-WEIGHT: bold; FONT-SIZE: 13px; COLOR: #666666; TEXT-DECORATION: = underline } .ns-headline { FONT-WEIGHT: bold; FONT-SIZE: 13px; COLOR: #000000 } .ns-title { FONT-WEIGHT: normal; FONT-SIZE: 18px; COLOR: #52a3db } .Summary-Table-Head { BACKGROUND-COLOR: #dce0e0 } A.SummaryRef-Small { FONT-SIZE: 7pt } A.SummaryRef-Small:hover { FONT-SIZE: 7pt } A.Summary-ProtocolRef-Small { FONT-SIZE: 7pt } A.Summary-ProtocolRef-Small:hover { FONT-SIZE: 7pt } A.Summary-LOERef-Small { FONT-SIZE: 7pt } A.Summary-LOERef-Small:hover { FONT-SIZE: 7pt } A.Summary-GlossaryTermRef-Small { FONT-SIZE: 7pt; COLOR: #4d4d4d; TEXT-DECORATION: underline } A.Summary-GlossaryTermRef-Small:active { FONT-SIZE: 7pt; COLOR: #4d4d4d; TEXT-DECORATION: underline } A.Summary-GlossaryTermRef-Small:visited { FONT-SIZE: 7pt; COLOR: #4d4d4d; TEXT-DECORATION: underline } A.Summary-GlossaryTermRef-Small:hover { FONT-SIZE: 7pt; COLOR: #000000; TEXT-DECORATION: underline } .Protocol-GeneName-Small { FONT-SIZE: 7pt; FONT-STYLE: italic } A.Protocol-ExternalRef-Small { FONT-SIZE: 7pt } A.Protocol-ExternalRef-Small:hover { FONT-SIZE: 7pt } A.SummarySection-Table-Small { FONT-SIZE: 7pt } A.SummarySection-Table-Small:hover { FONT-SIZE: 7pt } .QandA-Title { FONT-WEIGHT: bold; FONT-SIZE: 17px; COLOR: #000000 } OL.QandA-List { FONT-WEIGHT: bold } LI.QandA-ListItem { FONT-WEIGHT: bold } .QandA-Question { FONT-WEIGHT: bold } .QandA-Answer { FONT-WEIGHT: normal } .display-url { COLOR: #4d4d4d } UL LI { LIST-STYLE-IMAGE: url(/images/bullet_sm_css.gif); MARGIN-LEFT: -15px; = LIST-STYLE-TYPE: disc } UL.Protocol-UL { MARGIN-TOP: 5px; MARGIN-BOTTOM: 5px } OL.Protocol-OL { MARGIN-TOP: 5px; MARGIN-BOTTOM: 5px } ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://www.cancer.gov/stylesheets/nci_general_browsers.css UL LI { LIST-STYLE-IMAGE: url(/images/bullet_sm_css.gif); MARGIN-LEFT: -15px; = LIST-STYLE-TYPE: disc } OL LI { =09 } UL.Protocol-UL { MARGIN-TOP: 5px; MARGIN-BOTTOM: 5px } OL.Protocol-OL { MARGIN-TOP: 5px; MARGIN-BOTTOM: 5px } ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://www.cancer.gov/scripts/imgEvents.js ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://www.cancer.gov/scripts/popEvents.js ------=_NextPart_000_0000_01C7B8B5.52D8A6B0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://www.cancer.gov/scripts/NetTracker/ntpagetag.js /* NetTracker Page Tagging Script * Copyright 2004 Sane Solutions, LLC. All rights reserved. * Visit http://www.sane.com for more information. */ var NTPT_IMGSRC =3D '/images/ntpagetag.gif'; var NTPT_FLDS =3D new Object(); NTPT_FLDS.lc =3D true; // Document location NTPT_FLDS.rf =3D true; // Document referrer NTPT_FLDS.rs =3D true; // User's screen resolution NTPT_FLDS.cd =3D true; // User's color depth NTPT_FLDS.ln =3D true; // Browser language NTPT_FLDS.tz =3D true; // User's timezone NTPT_FLDS.jv =3D true; // Browser's Java support var NTPT_MAXTAGWAIT =3D 1.0; // Max delay (secs) on link-tags and = submit-tags // Optional variables: var NTPT_HTTPSIMGSRC =3D ''; var NTPT_GLBLEXTRA =3D ''; var NTPT_GLBLREFTOP =3D false; var NTPT_PGEXTRA =3D 'pv=3D1'; /*** END OF USER-CONFIGURABLE VARIABLES ***/ function = O0000(O0OO0O,OOO0O0O){return(eval("\x74\x79\x70\x65\x6f\x66\x20"+O0OO0O+"= \x20\x21\x3d\x20\x22\x75\x6e\x64\x65\x66\x69\x6e\x65\x64\x22")?eval(O0OO0= O):OOO0O0O);}function = OOOO000(OOOO0O,O0O000){return(OOOO0O+(((OOOO0O=3D=3D'')||((O0O000=3D=3D''= )||(O0O000.substring((0xdc3+3768-0x1c7b),(0x1219+1511-0x17ff))=3D=3D"\x26= ")))?'':"\x26")+O0O000);}function O0O00O(){var O00O00=3Dnew = Date();return(O00O00.getTime()+"\x2e"+Math.floor(Math.random()*(0x11f7+41= -0xe38)));}function = O0OOO(OOO0OO,O0OOO0){OO0OO[OOO0OO]=3DO0OOO0.toString();}function = O00OO0(OOO0OO){OO0OO[OOO0OO]=3D'';}function OO00OO0(OOOOO){var = O00OOO=3D'',OOO0O,OOO0O0;OOO000(O0000("\x4e\x54\x50\x54\x5f\x47\x4c\x42\x= 4c\x45\x58\x54\x52\x41",''));if(!LnkLck)OOO000(O0000("\x4e\x54\x50\x54\x5= f\x50\x47\x45\x58\x54\x52\x41",''));OOO000(OOOOO);for(OOO0O in = OO0OO){OOO0O0=3DOO0OO[OOO0O];if(OOO0O0&&(OOO0O0!=3D''))O00OOO=3DOOOO000(O= 00OOO,(OOO0O+"\x3d"+escape(OOO0O0)));}return O00OOO;}function = O0OO000(){var OOO0O;OO00O0.OO0OO=3Dnew Array();for(OOO0O in = OO0OO)OO00O0.OO0OO[OOO0O]=3DOO0OO[OOO0O];}function OOOOO0(){var = OOO0O;OO0OO=3Dnew Array();for(OOO0O in = OO00O0.OO0OO)OO0OO[OOO0O]=3DOO00O0.OO0OO[OOO0O];}function = OOO00O(O0O0O0,OO00OO,OOOO0){if(OO0O0[O0O0O0]!=3Dnull){var O00O0O=3Dnew = Function(OO00OO);OO0O0[O0O0O0].onload=3DO00O0O;OO0O0[O0O0O0].onerror=3DO0= 0O0O;OO0O0[O0O0O0].onabort=3DO00O0O;}setTimeout(OO00OO,(OOOO0*(0x1a5f+189= 5-0x1dde)));}function = OO0OO0(O0OO0,OOOO00){if(O0OO0=3D=3D'')return;O00OO=3D((O00OO+(0x1060+3795= -0x1f32))%OO0O0.length);if(OO0O0[O00OO]=3D=3Dnull)OO0O0[O00OO]=3Dnew = Image((0x1717+366-0x1884),(0xde0+520-0xfe7));OO0O0[O00OO].src=3DO0OO0+"\x= 3f"+OOOO00;}function OO0000(OOOOO){var O0OO0;var = OOOO00;if((OO000O!=3D'')&&(document.location.protocol=3D=3D"\x68\x74\x74\= x70\x73\x3a"))O0OO0=3DOO000O;else = O0OO0=3DO0OO00O;OOOO00=3DOO00OO0(OOOOO);OO0OO0(O0OO0,OOOO00);OOOOO0();}fu= nction OOO000(OOOOO){var OO0O00;var = O0OO00;if(!OOOOO)return;OOOOO=3DOOOOO.toString();if(OOOOO=3D=3D'')return;= OO0O00=3DOOOOO.split("\x26");for(O0OO00=3D(0xc96+706-0xf58);O0OO00(0x2e6+6443-0x1c11)){var = OO0O0O;if(O00O0.click){O00O0.tmpclck=3DO00O0.onclick;O00O0.onclick=3Dnull= ;OO0O0O=3D"\x69\x66\x20\x28\x20\x4c\x6e\x6b\x4c\x63\x6b\x20\x29\x20\x7b\x= 20\x4c\x6e\x6b\x4c\x63\x6b\x2e\x63\x6c\x69\x63\x6b\x28\x29\x3b\x20\x4c\x6= e\x6b\x4c\x63\x6b\x2e\x6f\x6e\x63\x6c\x69\x63\x6b\x20\x3d\x20\x4c\x6e\x6b= \x4c\x63\x6b\x2e\x74\x6d\x70\x63\x6c\x63\x6b\x3b\x20\x4c\x6e\x6b\x4c\x63\= x6b\x20\x3d\x20\x6e\x75\x6c\x6c\x3b\x20\x7d";}else = OO0O0O=3D"\x69\x66\x20\x28\x20\x4c\x6e\x6b\x4c\x63\x6b\x20\x29\x20\x7b\x2= 0\x77\x69\x6e\x64\x6f\x77\x2e\x6c\x6f\x63\x61\x74\x69\x6f\x6e\x2e\x68\x72= \x65\x66\x20\x3d\x20\x22"+O00O0.href+"\x22\x3b\x20\x4c\x6e\x6b\x4c\x63\x6= b\x20\x3d\x20\x6e\x75\x6c\x6c\x3b\x20\x7d";OOO00O(O00OO,OO0O0O,OO00O);ret= urn false;}LnkLck=3Dnull;return true;}function = O0O0O0O(OO000,OOOOO,OOOO0){var OO00O;if(!OO000||!OO000.submit)return = true;if(FrmLck)return = false;FrmLck=3DOO000;O0O0OO(OOOOO);if(OOOO0)OO00O=3DOOOO0;else = OO00O=3DNTPT_MAXTAGWAIT;if(OO00O>(0x157d+1827-0x1ca0)){OO000.tmpsbmt=3DOO= 000.onsubmit;OO000.onsubmit=3Dnull;OOO00O(O00OO,"\x69\x66\x20\x28\x20\x46= \x72\x6d\x4c\x63\x6b\x20\x29\x20\x7b\x20\x46\x72\x6d\x4c\x63\x6b\x2e\x73\= x75\x62\x6d\x69\x74\x28\x29\x3b\x20\x46\x72\x6d\x4c\x63\x6b\x2e\x6f\x6e\x= 73\x75\x62\x6d\x69\x74\x20\x3d\x20\x46\x72\x6d\x4c\x63\x6b\x2e\x74\x6d\x7= 0\x73\x62\x6d\x74\x3b\x20\x46\x72\x6d\x4c\x63\x6b\x20\x3d\x20\x6e\x75\x6c= \x6c\x3b\x20\x7d",OO00O);return false;}FrmLck=3Dnull;return true;}var = O0OO00O=3DNTPT_IMGSRC;var OOO00=3DNTPT_FLDS;var = OO000O=3DO0000("\x4e\x54\x50\x54\x5f\x48\x54\x54\x50\x53\x49\x4d\x47\x53\= x52\x43",'');var = O000OO=3DO0000("\x4e\x54\x50\x54\x5f\x50\x47\x52\x45\x46\x54\x4f\x50",O00= 00("\x4e\x54\x50\x54\x5f\x47\x4c\x42\x4c\x52\x45\x46\x54\x4f\x50",false))= ;var = O0000O=3DO0000("\x4e\x54\x50\x54\x5f\x4e\x4f\x49\x4e\x49\x54\x49\x41\x4c\= x54\x41\x47",false);var ntptAddPair=3DO0OOO;var = ntptDropPair=3DO00OO0;var ntptEventTag=3DO0O0OO;var = ntptLinkTag=3DO00000;var ntptSubmitTag=3DO0O0O0O;var OO0OO=3Dnew = Array();var OO00O0=3Dnew Object();var = OO0O0=3DArray((0x4e0+41-0x4ff));var = O00OO;for(O00OO=3D(0x27+2948-0xbab);O00OO(0x1904+3371-0x262d))O0O0O=3DO0O0O.substring((= 0xc13+2301-0x1510),(0x10a6+2670-0x1b12));O0O0O=3DO0O0O.toLowerCase();O0OO= O("\x6c\x6e",O0O0O);}if(OOO00.tz){var O0O00;var O00O00=3Dnew Date();var = O000O=3DO00O00.getTimezoneOffset();var = O000O0;O0O00=3D"\x47\x4d\x54";if(O000O!=3D(0x7f1+865-0xb52)){if(O000O>(0x= 12d5+3648-0x2115))O0O00+=3D"\x20\x2d";else = O0O00+=3D"\x20\x2b";O000O=3DMath.abs(O000O);O000O0=3DMath.floor(O000O/(0x= 13b3+2831-0x1e86));O000O-=3DO000O0*(0x1324+5143-0x26ff);if(O000O0<(0x3c9+= 541-0x5dc))O0O00+=3D"\x30";O0O00+=3DO000O0+"\x3a";if(O000O<(0x2192+484-0x= 236c))O0O00+=3D"\x30";O0O00+=3DO000O;}O0OOO("\x74\x7a",O0O00);}if(OOO00.j= v){var OO0OOO;if(navigator.javaEnabled())OO0OOO=3D"\x31";else = OO0OOO=3D"\x30";O0OOO("\x6a\x76",OO0OOO);}O0OO000();if(!O0000O)OO0000('')= ; ------=_NextPart_000_0000_01C7B8B5.52D8A6B0--